Robert Bray PhD
Academic Appointment
- Professor (CT), Winship Cancer Center
- Professor (CT), Department of Pathology and Laboratory Medicine, Emory University Hospital
Education
Degrees
- BS from Indiana University
- PhD from Indiana University School of Medicine
Research
Focus
- The thrust of my research has been almost exclusively applied clinical laboratory science. Since my training and clinical responsibilities encompass two quite distinct entities, my research has also moved in several directions. However, an underlying theme has been the application of State-of-the-Art technology, specifically Flow Cytometry and Luminex, to advances in diagnostic testing.
Publications
-
Antigen quantity is responsible for the discrepancy between phenotype and single antigen beads for the detection of HLA-DQ antibody: potential clinical implications.
Am J Transplant
04/12/2025 Authors: Shih NR; Nong T; Bray RA; Murphey C; Skaljic I; Gebel HM; Lopez-Cepero M; Nickerson PW; Lee J-H -
From hero to zero: a single center retrospective review of the utility of routine physical crossmatching.
Am J Transplant
01/13/2025 Authors: Bray RA; Morris AB; Patel L; Bray R; Gebel HM; Sullivan HC -
Hiding in plain sight: Misinterpretation of immunogenic DPB epitopes within G/P groups.
Hum Immunol Volume: 85 Page(s): 111115
11/01/2024 Authors: Morris AB; Achram R; Cliff Sullivan H; Gebel HM; Bray RA -
Mitigating the Prozone-Like Effect in HLA Antibody Testing: A Case Report of Therapeutic Plasma Exchange for Antibody-Mediated Rejection Post-Heart Transplantation.
J Clin Apher Volume: 39 Page(s): e22144
10/01/2024 Authors: Grewal SK; Achram R; Nakahara H; Roback JD; Morris AB; Gebel HM; Bray RA; Sullivan HC -
Identification of Antibodies to DQ:DR Interisotypic Heterodimers in Human Sera.
Transplantation Volume: 108 Page(s): 1142 - 1148
05/01/2024 Authors: Nong T; Shih NR; Bray RA; Lopez-Cepero M; Murphey C; Nickerson PW; Lee J-H -
HLA class I peptide polymorphisms contribute to class II DQ0603:DQ0103 antibody specificity.
Nat Commun Volume: 15 Page(s): 609
01/19/2024 Authors: Shih NR; Nong T; Murphey C; Lopez-Cepero M; Nickerson PW; Taupin J-L; Devriese M; Nilsson J; Matignon M-B; Bray RA -
The Virtual Crossmatch: What's in a Name?
Transplantation Volume: 107 Page(s): e273
10/01/2023 Authors: Bray RA; Morris AB; Sullivan HC; Gebel HM -
A Primer on Chimerism Analysis: A Straightforward, Thorough Review.
Lab Med Volume: 54 Page(s): 352 - 362
07/05/2023 Authors: Morris AB; Bray R; Gebel HM; Cliff Sullivan H -
The evolving use of biomarkers in heart transplantation: Consensus of an expert panel.
Am J Transplant Volume: 23 Page(s): 727 - 735
06/01/2023 Authors: Kobashigawa J; Hall S; Shah P; Fine B; Halloran P; Jackson AM; Khush KK; Margulies KB; Sani MM; Patel JK -
COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohort.
Hum Immunol Volume: 84 Page(s): 278 - 285
04/01/2023 Authors: Roll GR; Bray RA; Cooper M; Eagar TN; Gebel HM; Vranic GM; Hitchman KMK; Houp J; Kamoun M; Killian J -
Identification of the novel HLA-B*08:79:02 allele by next generation sequencing.
HLA Volume: 101 Page(s): 161 - 162
02/01/2023 Authors: Shah Z; Weingard P; Toddings R; Bray R -
Loss of heterozygosity leading to incorrect HLA typing for platelet-transfusion refractory patient.
Volume: 63 Page(s): 263 - 268
01/01/2023 Authors: Horwath M; Tvrdik T; Saxe D; Deeb KK; Roback JD; Gebel HM; Bray RA; Sullivan HC -
Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients.
Transpl Immunol Volume: 75 Page(s): 101722
12/01/2022 Authors: McCune TR; Bray RA; Baran DA; Toepp AJ; Forte SJ; Gilgannon LT; Williams T; Chen S; Sadr H; Gebel HM -
Establishing a combined Immunology/HLA/Coagulation Rotation for Pathology Residents
Volume: 158 Page(s): S4 - S5
11/09/2022 Authors: Dent EA; Duncan A; Sullivan HC; Gebel HM; Bray RA; Maier CL; Smith G; Guarner J -
IDENTIFICATION OF TWO NEW SEROLOGICALLY DEFINED EPITOPES.
Volume: 83 Page(s): 54 - 55
11/01/2022 Authors: Castlin D; Abraham J; Toddings R; Bray RA -
IDENTIFICATION OF DISTINCT DQ4 REACTIVITIES VIA MULTIPLE ANTIBODY ASSAYS: NOT ALL ASSAYS ARE CREATED EQUAL
Volume: 83 Page(s): 97 - 97
11/01/2022 Authors: Bray RA; Tate C; Abraham J; Toddings R -
A SIMPLIFIED APPROACH FOR PERFORMING COMPARABILITY ASSESSMENTS ACROSS MULTIPLE LUMINEX INSTRUMENTS.
Volume: 83 Page(s): 181 - 182
11/01/2022 Authors: Toddings R; Bray RA; Yurekci E; Weingard P -
MONITORING DONOR LYMPHOID CHIMERISM AND DE NOVO ANTI-RECIPIENT SPECIFIC HLA ANTIBODY IN ASSISTING DIAGNOSIS AND TREATMENT OF GRAFT VS. HOST DISEASE AFTER INTESTINE-CONTAINED TRANSPLANTATION
Volume: 83 Page(s): 112 - 113
11/01/2022 Authors: Zhang A; Thomas D; Allen J; Kawczak P; Macecevic S; Zimmerman K; Arnst C; Calabrese L; Bray RA; Gebel HM -
COVID-19 Infection Does Not Alter HLA Antibody Reactivity.
Kidney Int Rep Volume: 7 Page(s): 2279 - 2282
10/01/2022 Authors: Johnson AC; Larsen CP; Gebel H; Bray R -
Tirzepatide leads to significant improvement in postprandial glycaemic control in people with type 2 diabetes (SURPASS 1-5)
Volume: 65 Page(s): S300 - S301
09/01/2022 Authors: Lee CJ; Spanakis E; Bray R; Brown K; Billings LK; Chivukula K; Rodriguez A; Giorgino F -
Implementing virtual crossmatch based diagnostic management teams in human leukocyte antigen laboratories and transplant programs.
Transpl Immunol Volume: 73 Page(s): 101629
08/01/2022 Authors: Wade J; Roback JD; Krummey SM; Gebel HM; Bray RA; Sullivan HC -
Anti-HLA Antibodies Do Not Increase in Kidney Transplant Recipients During COVID-19 Infection.
Volume: 22 Page(s): 709 - 709
06/01/2022 Authors: Girnita A; Wang L; Ahearn P; Colovai A; Fernandez-Vina M; Woodle E; Yalamarti T; Menon M; Azzi Y; Melcher M -
Immunogenicity after heterologous third dose COVID-19 vaccination in a heart transplant recipient.
Clin Transplant Volume: 36 Page(s): e14605
04/01/2022 Authors: Mehta SA; Reyentovich A; Montgomery RA; Segev DL; Gebel HM; Bray RA; Samanovic MI; Cornelius AR; Mulligan MJ; Herati RS -
From antigens to eplets: The evolution of HLA.
Hum Immunol Volume: 83 Page(s): 197 - 198
03/01/2022 Authors: Gebel HM; Norin AJ; Bray RA -
hlaR: A rapid and reproducible tool to identify eplet mismatches between transplant donors and recipients.
Hum Immunol Volume: 83 Page(s): 248 - 255
03/01/2022 Authors: Johnson AC; Zhang J; Cliff Sullivan H; Wiebe C; Bray R; Gebel H; Larsen CP -
Employment status at transplant influences ethnic disparities in outcomes after deceased donor kidney transplantation.
BMC Nephrol Volume: 23 Page(s): 6
01/03/2022 Authors: Divers J; Mohan S; Brown WM; Pastan SO; Israni AK; Gaston RS; Bray R; Islam S; Sakhovskaya NV; Mena-Gutierrez AM -
Belatacept in Kidney Transplant Recipients With Failed Allografts for the Prevention of Humoral Sensitization: A Pilot Randomized Controlled Trial.
Transplantation Volume: 105 Page(s): e395 - e396
12/01/2021 Authors: Badell IR; Bray RA; Elbein R; Chami AS; Easley KA; Pastan SO; Guasch A; Gebel HM; Adams AB; Larsen CP -
Eplet mismatch imputation studies should include immunologic risk assessment.
Am J Transplant Volume: 21 Page(s): 3500 - 3501
10/01/2021 Authors: Krummey SM; Bray RA; Gebel HM; Sullivan HC -
RELATIONSHIP BETWEEN MFI, FlowPRA AND FCXM EMPLOYING A MONOTYPIC DRB4(DR53) ALLOANTIBODY
Volume: 82 Page(s): 62 - 62
09/01/2021 Authors: Abraham J; Flynn D; Tate C; Sullivan HC; Gebel HM; Bray RA -
MINIMIZING INTER-TECHNOLOGIST VARIABILITY FOR CLASS I SINGLE ANTIGEN ANTIBODY TESTING
Volume: 82 Page(s): 152 - 152
09/01/2021 Authors: Sullivan HC; Toddings R; Muchhala M; Gebel HM; Bray RA -
OPTIMIZING TEST UTILIZATION IN HIGHLY SENSITIZED PATIENTS
Volume: 82 Page(s): 155 - 155
09/01/2021 Authors: Sullivan HC; Taylor A; Hennig F; Gebel HM; Bray RA -
Reducing Donor Specific Antibody via Therapeutic Plasma Exchange: Daily vs Every Other Day Protocols
Volume: 61 Page(s): 23A - 23A
09/01/2021 Authors: Wade J; Goodman A; Dent AE; Duncan A; Roback JD; Bray RA; Gebel HM; Sullivan HC -
Risk Factors Related to Minor Blood Group Antibodies in Renal Transplant Candidates: The Role of HLA Antibodies
Volume: 61 Page(s): 146A - 146A
09/01/2021 Authors: Wade J; Dent AE; Roback JD; Easley KA; Bray RA; Gebel HM; Sullivan HC -
COVID-19 in the Kidney Transplant Waitlist Population
Volume: 21 Page(s): 313 - 313
06/01/2021 Authors: Johnson AC; Larsen CP; Gebel H; Bray R -
Quantification of Multiple Isotypes of Anti-SARS-CoV-2 Antibodies in Kidney Transplant Recipients
Volume: 21 Page(s): 863 - 863
06/01/2021 Authors: Maltzman JS; Wang L; Ahearn P; Yalamarti T; Menon M; Azzi Y; Melcher M; Fernandez-Vina M; Bray R; Gebel H -
Donor-specific Anti-HLA Alloantibody in Kidney Transplant Recipients with COVID-19 Exhibit a Different Immunoglobulin Class and Subclass Profile When Compared to Anti-SARS-CoV-2 Antibodies
Volume: 21 Page(s): 863 - 863
06/01/2021 Authors: Girnita A; Wang L; Fernandez-Vina M; Woodle E; Ahearn P; Yalamarti T; Menon M; Azzi Y; Melcher M; Bray R -
Development and Validation of a Multiplex, Bead-based Assay to Detect Antibodies Directed Against SARS-CoV-2 Proteins.
Transplantation Volume: 105 Page(s): 79 - 89
01/01/2021 Authors: Bray RA; Lee J-H; Brescia P; Kumar D; Nong T; Shih R; Woodle ES; Maltzman JS; Gebel HM -
Stem cell donor HLA typing improves CPRA in kidney allocation.
Am J Transplant Volume: 21 Page(s): 138 - 147
01/01/2021 Authors: Kransdorf EP; Pando MJ; Stewart D; Lindblad K; Bray R; Murphey C; Kaur N; Patel JK; Kim I; Zhang X -
The utility of second single antigen bead assay: Clearing the water or stirring up mud?
Hum Immunol Volume: 81 Page(s): 663 - 670
12/01/2020 Authors: Sullivan HC; Krummey SM; Gebel HM; Bray RA -
PERFORMANCE OF VIRTUAL CROSSMATCH IN HIGH CPRA PATIENTS
Volume: 81 Page(s): 90 - 90
11/01/2020 Authors: Krummey S; Larsen C; Gebel HM; Bray RA; Sullivan HC -
ABO ANTIBODY DETECTION: COMPARING APPLES TO APPLES IN A MULTI-SITE LUMINEX TOOL EVALUATION
Volume: 81 Page(s): 36 - 37
11/01/2020 Authors: Halpin AM; Bray RA; Cairo CW; Campbell PM; Chen D; Dijke E; Ellis T; Gebel HM; Greenshields A; Heidt S -
HLA ANTIBODY MARKUP LANGUAGE (HAML) - A CASE STUDY AND TECHNOLOGY DEMONSTRATION INVOLVING DPB1 EPITOPE ANALYSIS
Volume: 81 Page(s): 82 - 82
11/01/2020 Authors: Gragert LA; Smith GH; Spierings E; Matern BM; Fischer G; Dribus M; Gebel HM; Bray RA -
QUALITY METRICS AND CLINICAL UTILITY OF VIRTUAL CROSSMATCH REPORTS
Volume: 81 Page(s): 49 - 49
11/01/2020 Authors: Sullivan HC; Krummey SM; Gebel HM; Bray RA -
REACTIVITY OF PATIENT PRE-TRANSPLANT SERA WITH NON-HLA COATED LUMINEX BEADS
Volume: 81 Page(s): 50 - 50
11/01/2020 Authors: Ray BL; Hariharan J; Malireddy H; Gebel HM; Bray RA -
HIGH DEGREE OF AGREEMENT BETWEEN EPITOPE MISMATCH BURDEN DETERMINED BY HAPLOTYPE IMPUTATION AS COMPARED WITH HIGH RESOLUTION GENOTYPING
Volume: 81 Page(s): 92 - 92
11/01/2020 Authors: Krummey S; Bray RA; Gebel HM; Sullivan HC -
Investigating complement mediated interference in class I HLA-specific antibodies following renal transplantation.
Transpl Immunol Volume: 62 Page(s): 101310
10/01/2020 Authors: Goldsmith P; Lowe D; Wong C; Howse M; Ridgway D; Hammad A; Mehra S; Christmas S; Gebel H; Bray R -
Physical Crossmatching vs Virtual Crossmatching: The end of an era? or Why give up a good thing?
Hum Immunol Volume: 81 Page(s): 401 - 406
08/01/2020 Authors: Clifford Sullivan H; Krummey SM; Gebel HM; Bray RA; Jackson AM -
A simple electronic tool for assessing amino acid sequence polymorphisms within exon-2 of HLA-DPB1 alleles.
Hum Immunol Volume: 81 Page(s): 430 - 436
08/01/2020 Authors: Sullivan HC; Gragert L; Smith GH; Lindblad K; Gebel HM; Bray RA -
A Multicenter Analysis of the Proportion and Pattern of Unexplained HLA Antibodies in Kidney Recipients without a History of Sensitization
Volume: 20 Page(s): 708 - 708
04/01/2020 Authors: Lan J; Gill JS; Gebel HM; Bray RA; Liwski R; Vinson A; Greenshields A; Dobrer S; Gunther O; Sherwood K -
Anticipated Observations: The Role of DQ Antigen Frequencies among Donors and Recipients in a Pediatric Renal Transplant Cohort
Volume: 20 Page(s): 707 - 707
04/01/2020 Authors: Gattis S; George R; Liverman R; Serluco A; Garro R; Figueroa J; Bray RA; Gebel HM; Sullivan HC -
The impact of belatacept on third-party HLA alloantibodies in highly sensitized kidney transplant recipients.
Am J Transplant Volume: 20 Page(s): 573 - 581
02/01/2020 Authors: Parsons RF; Zahid A; Bumb S; Decker H; Sullivan HC; Eun-Hyung Lee F; Badell IR; Ford ML; Larsen CP; Pearson TC -
A blueprint for electronic utilization of ambiguous molecular HLA typing data in organ allocation systems and virtual crossmatch.
Hum Immunol Volume: 81 Page(s): 65 - 72
01/01/2020 Authors: Kaur N; Pinelli D; Kransdorf EP; Pando MJ; Smith G; Murphey CL; Kamoun M; Bray RA; Tambur A; Gragert L -
Identification of a recurrent pattern of false-positivity by Luminex HLA MHC class I single antigen bead testing.
Hum Immunol Volume: 81 Page(s): 73 - 78
01/01/2020 Authors: Dean CL; Krummey SM; Gebel HM; Bray RA; Sullivan HC -
Out with the old, in with the new: Virtual versus physical crossmatching in the modern era.
HLA Volume: 94 Page(s): 471 - 481
12/01/2019 Authors: Morris AB; Sullivan HC; Krummey SM; Gebel HM; Bray RA -
The impact of transfused blood products on deceased donor HLA typing.
Hum Immunol Volume: 80 Page(s): 976 - 982
12/01/2019 Authors: Jacob RP; Dean CL; Krummey SM; Shah Z; Sutherland N; Orear C; Gebel HM; Bray RA; Sullivan HC -
THE GREAT DIVIDE(R): EVIDENCE FOR REMOVING THE MFI DIVIDER ON THE FLEXMAP 3D
Volume: 80 Page(s): 111 - 111
09/01/2019 Authors: McRacken T; Stephens M; Fortes W; Loescher J; Phelps E; Erica S; Gebel HM; Bray RA -
A NOVEL REACTIVITY PATTERN WITH LABSCREEN (TM) CLASS II SINGLE ANTIGEN BEADS
Volume: 80 Page(s): 197 - 197
09/01/2019 Authors: Dean CL; Krummey S; Gebel HM; Bray RA; Sullivan HC -
DIAGNOSTIC MANAGEMENT TEAM: A VIRTUAL CROSSMATCH CONSULT
Volume: 80 Page(s): 114 - 114
09/01/2019 Authors: Sullivan HC; Krummey SC; Wilmoth-Hosey; Lisa LC; Toddings R; Gebel HM; Bray RA -
DPB1 GENE AND UNACCEPTABLE ANTIGEN FREQUENCIES FROM OPTN DECEASED DONORS AND WAITLISTED CANDIDATES
Volume: 80 Page(s): 170 - 171
09/01/2019 Authors: Lindblad K; Murphey CL; Lalli P; Wholley C; Bray RA -
RENAL ALLOGRAFT CHRONIC ACTIVE INFLAMMATION/REJECTION: ANALYSIS OF BANFF TI AND I-IFTA LESIONS IN A CONTEMPORARY BIOPSY COHORT
Volume: 80 Page(s): 213 - 213
09/01/2019 Authors: Farris AB; Ellis CL; Rogers TE; Sullivan HC; Gebel HM; Bray RA; Hogan J; Vasanth P -
IMPACT OF CLASS II INVARIANT CHAIN PEPTIDE (CLIP) IN HLA ALLOANTIBODY RECOGNITION
Volume: 80 Page(s): 7 - 8
09/01/2019 Authors: Bray RA; Nguyen J; Shih R; Ma H; Pei R; Thao D; Lee J-H -
THE ASSOCIATION OF NON-HLA AUTOANTIBODY TO ANTIBODY MEDIATED REJECTION AND CHRONIC LUNG ALLOGRAFT DYSFUNCTION AFTER LUNG TRANSPLANTATION
Volume: 80 Page(s): 48 - 49
09/01/2019 Authors: Zhang A; Thomas DM; Pei R; Sun Y; Allen J; Winn E; Bray RA; Gebel HM; Budev M -
DE NOVO THIRD PARTY HLA ANTIBODIES SYNERGIZE WITH DE NOVO DONOR SPECIFIC HLA ANTIBODIES TO NEGATIVELY IMPACT LUNG ALLOGRAFT OUTCOME
Volume: 80 Page(s): 32 - 33
09/01/2019 Authors: Zhang A; Good DJ; Thomas DM; Walendzik A; Cagahastian V; Allen J; McMichael J; McCurry K; Budev M; Gebel HM -
A diagnostic 'C' saw: the ups and downs of C1q testing.
Curr Opin Organ Transplant Volume: 24 Page(s): 402 - 410
08/01/2019 Authors: Gebel HM; Bray RA -
Getting on target: Development of the novel, prozone-resistant, dual antibody rapid test (DART) for the LABScreen single antigen bead (SAB) assay.
Hum Immunol Volume: 80 Page(s): 468 - 477
07/01/2019 Authors: Greenshields A; Bray RA; Gebel HM; Liwski RS -
Incidence of de novo donor specific antibodies and treatment response for amr in pediatric kidney transplant recipients
Volume: 23
05/01/2019 Authors: Gattis S; Liverman R; Serluco A; Yin J; Sullivan HC; Hogan J; Bray RA; Gebel HM; Jernigan S; George R -
Impact of HLA-DR Matching on HLA-DQ Matching Status and the Development of Anti-HLA-DQ De Novo DSA under Calcineurin Inhibitor or Belatacept Immunosuppression.
Volume: 19 Page(s): 699 - 700
04/01/2019 Authors: Jucaud V; Gebel H; Bray R; Polinsky M; Everly M -
Mismatched Epitope and De Novo DSA Development: An Analysis of the Benefit and Benefit-EXT Renal Transplant Cohorts.
Volume: 19 Page(s): 384 - 384
04/01/2019 Authors: Jucaud V; Burnett V; Gebel H; Bray R; Polinsky M; Everly M -
Reduction of Pre-Existing Alloantibodies in Highly Sensitized Belatacept-Treated Kidney Recipients.
Volume: 19 Page(s): 810 - 810
04/01/2019 Authors: Parsons RF; Bumb S; Decker H; Zahid A; Sullivan C; Pearson T; Larsen C; Levine M; Kamoun M; Bray RA -
Incidence of De Novo Donor Specific Antibodies and Treatment Response for AMR in Pediatric Kidney Transplant Recipients
Volume: 19 Page(s): 1065 - 1066
04/01/2019 Authors: Gattis S; Liverman R; Serluco A; Yin J; Sullivan HC; Bray RA; Gebel HM; Jernigan S; George R; Winterberg PD -
Belatacept Monotherapy in Kidney Transplant Recipients with Failed Allografts Reduces Humoral Sensitization in a Single Center Randomized Controlled Trial.
AMERICAN JOURNAL OF TRANSPLANTATION Volume: 19 Page(s): 450 - 450
04/01/2019 Authors: Badell IR; Elbein R; Bray RA; Gebel HM; Adams AB; Larsen CP -
Severe Arteritis in Kidney Allografts (Banff v2 to v3 arteritis): Clinicopathologic Correlations
Volume: 32
03/01/2019 Authors: Farris A; Ellis C; Rogers T; Sullivan H; Gebel H; Bray R; Vasanth P -
Severe Arteritis in Kidney Allografts (Banff v2 to v3 arteritis): Clinicopathologic Correlations
Volume: 99
03/01/2019 Authors: Farris A; Ellis C; Rogers T; Sullivan H; Gebel H; Bray R; Vasanth P -
Kidney Allograft Chronic Active Inflammation/Rejection: Analysis of Banff ti and i-IFTA Lesions in the Context of Contemporary Biopsies
Volume: 99
03/01/2019 Authors: Farris A; Ellis C; Rogers T; Sullivan H; Gebel H; Bray R; Vasanth P -
Kidney Allograft Chronic Active Inflammation/Rejection: Analysis of Banff ti and i-IFTA Lesions in the Context of Contemporary Biopsies
Volume: 32
03/01/2019 Authors: Farris A; Ellis C; Rogers T; Sullivan H; Gebel H; Bray R; Vasanth P -
ERRATUM.
Transfusion Volume: 59 Page(s): 827
02/01/2019 -
Stability of anti-A blood group titers among blood group B renal transplant candidates.
Transfusion Volume: 58 Page(s): 2747 - 2751
12/01/2018 Authors: Jacob RP; Dean CL; Krummey SM; Goodman AL; Roback JD; Gebel HM; Bray RA; Sullivan HC -
Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants.
Gastroenterology Volume: 155 Page(s): 1838 - 1851.e7
12/01/2018 Authors: Feng S; Bucuvalas JC; Demetris AJ; Burrell BE; Spain KM; Kanaparthi S; Magee JC; Ikle D; Lesniak A; Lozano JJ -
Mapping molecular HLA typing data to UNOS antigen equivalents.
Hum Immunol Volume: 79 Page(s): 781 - 789
11/01/2018 Authors: Kaur N; Kransdorf EP; Pando MJ; Maiers M; Ray B; Lee J-H; Lalli P; Murphey CL; Bray RA; Gragert L -
(F)Utility of the physical crossmatch for living donor evaluations in the age of the virtual crossmatch.
Hum Immunol Volume: 79 Page(s): 711 - 715
10/01/2018 Authors: Sullivan HC; Dean CL; Liwski RS; Biswas S; Goodman AL; Krummey S; Gebel HM; Bray RA -
Prevalence of HLA-Alloantibodies in a Cohort of Men Who Have Sex with Men
Volume: 58 Page(s): 242A - 242A
10/01/2018 Authors: Sullivan H; Kelley CF; Dean CL; Sullivan PS; Biswas S; Roback JD; Bray RA; Gebel HM -
HLA EPITOPE-MISMATCH MORE PRECISELY PREDICTS THE DEVELOPMENT OF DE NOVO DONOR SPECIFIC ANTIBODY AND ACUTE CELLULAR REJECTION AFTER LUNG TRANSPLANT
Volume: 79 Page(s): 21 - 22
10/01/2018 Authors: Zhang A; Stopczynski N; Thomas D; Sun Y; McMichael J; Kawczak P; Allen J; Budev M; Bray RA; Gebel H -
CHARACTERISTICS OF TRANSPLANT CANDIDATES WITH CPRA >= 99.95% LIKELY TO BE ALLOCATED ORGANS FROM DECEASED DONORS
Volume: 79 Page(s): 17 - 17
10/01/2018 Authors: Parsons R; Decker H; Patzer R; Bumb S; Sullivan HC; Bray RA; Gebel HM -
EFFECT OF LEUKOREDUCTION OF TRANSFUSED BLOOD PRODUCTS ON DECEASED DONOR HLA TYPING
Volume: 79 Page(s): 126 - 126
10/01/2018 Authors: Sullivan HC; Krummey SM; Dean C; Shah Z; Sutherland N; Bray RA; Gebel HM -
RACIAL INEQUITY AMONG 0-ABDR MISMATCHED KIDNEY RECIPIENTS
Volume: 79 Page(s): 48 - 48
10/01/2018 Authors: Bray RA; Gebel HM -
A NOVEL REACTIVITY PATTERN WITH LABSCREENN (TM) CLASS I SINGLE ANTIGEN BEADS AND ITS PREVALENCE AMONG SLE PATIENTS
Volume: 79 Page(s): 15 - 15
10/01/2018 Authors: Dean CL; Bray RA; Gebel HM; Sullivan HC -
Testing for Platelet Refractoriness: Optimizing Testing Algorithms
Volume: 150 Page(s): S151 - S151
10/01/2018 Authors: Wade J; Dean CL; Roback JD; Gebel HM; Bray RA; Sullivan HC -
Comparison of de novo IgM and IgG anti-HLA DSAs between belatacept- and calcineurin-treated patients: An analysis of the BENEFIT and BENEFIT-EXT trial cohorts.
Am J Transplant Volume: 18 Page(s): 2305 - 2313
09/01/2018 Authors: Everly MJ; Roberts M; Townsend R; Bray RA; Gebel HM -
De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies.
Am J Transplant Volume: 18 Page(s): 1783 - 1789
07/01/2018 Authors: Bray RA; Gebel HM; Townsend R; Roberts ME; Polinsky M; Yang L; Meier-Kriesche H-U; Larsen CP -
Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXT.
Am J Transplant Volume: 18 Page(s): 1774 - 1782
07/01/2018 Authors: Bray RA; Gebel HM; Townsend R; Roberts ME; Polinsky M; Yang L; Meier-Kriesche H-U; Larsen CP -
Identifying Patients with CPRA > 99.95% Likely to Be Offered Deceased Donor Kidneys.
Volume: 18 Page(s): 982 - 982
06/01/2018 Authors: Parsons R; Bumb S; Decker H; Bray R; Gebel H -
Determining the Relative Immunogenicity of HLA Mismatches with Calcineurin Inhibitor Immunosuppression: An Analysis of the BENEFIT and BENEFIT-EXT Renal Transplant Cohort.
Volume: 18 Page(s): 289 - 290
06/01/2018 Authors: Jucaud V; Roberts M; Gebel H; Bray R; Everly M -
Immunogenic HLA Mismatches and Evidence That Belatacept May Be the First Therapy Able to Prevent DQ De Novo DSA: An Analysis of the BENEFIT and BENEFIT-EXT Trial Cohorts.
Volume: 18 Page(s): 780 - 780
06/01/2018 Authors: Everly M; Jucaud V; Roberts M; Gebel H; Bray R -
Increasing the Donor Pool for Highly Sensitized Patients with Allele Specific Antibodies: Optimizing the Virtual Crossmatch (vXM).
Volume: 18 Page(s): 445 - 445
06/01/2018 Authors: Zhang A; Zaky Z; Africa J; Good D; Bray R; Gebel H -
Epitope/Eplet Mismatch in Pediatric Renal Transplantation and Development of Donor Specific Antibody.
Volume: 18 Page(s): 267 - 267
06/01/2018 Authors: George R; Sullivan H; Garro R; Winterberg P; Warshaw B; Gebel H; Bray R -
Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantation.
J Heart Lung Transplant Volume: 37 Page(s): 503 - 512
04/01/2018 Authors: Cole RT; Gandhi J; Bray RA; Gebel HM; Yin M; Shekiladze N; Young A; Grant A; Mahoney I; Laskar SR -
Transplant Glomerulopathy in the Contemporary Immunosuppression Era: Clues to a Diverse Pathogenesis, Including Etiologies Other Than Donor Specific Antibody
Volume: 31 Page(s): 610 - 610
03/01/2018 Authors: Farris AB; Ellis CL; Sullivan H; Bray RA; Gebel H; Rogers TE; Vasanth P -
Banff Renal Allograft v2 Arteritis: Heterogeneous Clinicopathologic Entity Confirmable by Morphometry Representing Acute Cellular Rejection, Type IIB or not IIB?
Volume: 31 Page(s): 609 - 610
03/01/2018 Authors: Farris AB; Ellis CL; Sullivan H; Bray RA; Gebel H; Rogers TE; Vasanth P -
Transplant Glomerulopathy in the Contemporary Immunosuppression Era: Clues to a Diverse Pathogenesis, Including Etiologies Other Than Donor Specific Antibody
Volume: 98 Page(s): 610 - 610
03/01/2018 Authors: Farris AB; Ellis CL; Sullivan H; Bray RA; Gebel H; Rogers TE; Vasanth P -
Banff Renal Allograft v2 Arteritis: Heterogeneous Clinicopathologic Entity Confirmable by Morphometry Representing Acute Cellular Rejection, Type IIB or not IIB?
Volume: 98 Page(s): 609 - 610
03/01/2018 Authors: Farris AB; Ellis CL; Sullivan H; Bray RA; Gebel H; Rogers TE; Vasanth P -
POST-TRANSPLANT REDUCTION IN PRE-EXISTING DONOR-SPECIFIC ANTIBODY LEVELS AFTER BELATACEPT-VS CYCLOSPORINE-BASED IMMUNOSUPPRESSION
Volume: 31 Page(s): 20 - 21
01/01/2018 Authors: Bray R; Gebel H; Townsend R; Polinsky M; Yang L; Meier-Kriesche U; Larsen C -
Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols.
Hum Immunol Volume: 79 Page(s): 28 - 38
01/01/2018 Authors: Liwski RS; Greenshields AL; Conrad DM; Murphey C; Bray RA; Neumann J; Gebel HM -
Becoming a chef in the human leukocyte antigen kitchen: interpretation and modification of human leukocyte antigen-antibody assays.
Curr Opin Organ Transplant Volume: 22 Page(s): 407 - 414
08/01/2017 Authors: Liwski RS; Greenshields AL; Bray RA; Gebel HM -
The Road to HLA Antibody Evaluation: Do Not Rely on MFI.
Am J Transplant Volume: 17 Page(s): 1455 - 1461
06/01/2017 Authors: Sullivan HC; Liwski RS; Bray RA; Gebel HM -
De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantation.
Volume: 31
04/01/2017 Authors: Cole RT; Gandhi J; Bray RA; Gebel HM; Morris A; McCue A; Yin M; Laskar SR; Book W; Jokhadar M -
Reduced Conversion from IgM Anti-HLA-DSA to IgG Anti-HLA-DSA in Belatacept-Treated vs. Cyclosporine-Treated Patients in BENEFIT and BENEFIT-EXT Trials
Volume: 17 Page(s): 266 - 267
04/01/2017 Authors: Everly M; Townsend R; Gebel H; Bray R -
Post-Transplant Reduction in Pre-Existing Donor-Specific Antibody Levels After Belatacept-vs Cyclosporine-Based Immunosuppression
Volume: 17 Page(s): 267 - 268
04/01/2017 Authors: Bray R; Gebel H; Townsend R; Polinsky M; Yang L; Meier-Kriesche U; Larsen C -
Even with National Sharing, the Prospects of a 100% Sensitized Patient Receiving a Transplant Vary Dramatically Depending on the Precise CPRA Value
Volume: 17 Page(s): 243 - 243
04/01/2017 Authors: Stewart D; Kucheryavaya A; Tyan D; Gebel H; Bray R; Turgeon N -
Genotyping Applications for Transplantation and Transfusion Management: The Emory Experience.
Arch Pathol Lab Med Volume: 141 Page(s): 329 - 340
03/01/2017 Authors: Fasano RM; Sullivan HC; Bray RA; Gebel HM; Meyer EK; Winkler AM; Josephson CD; Stowell SR; Sandy Duncan A; Roback JD -
EVALUATION OF DISCREPANT DECEASED DONOR HLA TYPINGS REPORTED IN UNET
Volume: 78 Page(s): 92 - 92
01/01/2017 Authors: Lalli P; Murphey CL; Kucheryavaya AY; Bray RA -
GETTING ON TARGET: DEVELOPMENT OF THE NOVEL, PROZONE-RESISTANT, DUAL ANTIBODY RAPID TEST (DART) FOR THE LABSCREEN SINGLE ANTIGEN BEAD (SAB) ASSAY
Volume: 78 Page(s): 70 - 70
01/01/2017 Authors: Greenshields AL; Bray RA; Gebel HM; Liwski RS -
FACTORS THA IMPACT DOWNREGULATION OF HLA ANTIBODIES IN HEART TRANSPLANT CANDIDATES
Volume: 78 Page(s): 96 - 96
01/01/2017 Authors: Ingemi A; McRacken T; Herre J; Bray RA; Gebel HM -
VIRTUAL CROSSMATCHING SUCCESSFULLY EXTENDED DONOR POOL FOR HIGHLY SENSITIZED PATIENTS WITH ALLELE SPECIFIC ANTIBODIES
Volume: 78 Page(s): 125 - +
01/01/2017 Authors: Zhang A; Zaky Z; Africa J; Good D; Walendzik A; Sun Y; Bray R; Gebel HM -
UTILITY OF THE VIRTUAL CROSSMATCH FOR LIVING DONOR EVALUATIONS
Volume: 78 Page(s): 168 - 168
01/01/2017 Authors: Sullivan HC; Dean CL; Goodman AL; Bray RA; Gebel HM -
REMOVAL OF SELECTED NON-SPECIFIC REACTIVITY IN SINGLE ANTIGEN BEAD ASSAYS VIA FBS PRE-TREATMENT
Volume: 78 Page(s): 65 - 65
01/01/2017 Authors: Waslaske SH; McPherson EM; Gebel HM; Bray RA -
STABILITY OF ANTI-A2 BLOOD GROUP SUBTYPE TITERS AMONG BLOOD GROUP B CANDIDATES
Volume: 78 Page(s): 88 - 88
01/01/2017 Authors: Sullivan HC; Dean CL; Krummey SM; Jacob RP; Goodman AL; Gebel HM; Bray RA -
Understanding solid-phase HLA antibody assays and the value of MFI.
Hum Immunol Volume: 78 Page(s): 471 - 480
01/01/2017 Authors: Sullivan HC; Gebel HM; Bray RA -
It's about time: The development and validation of a rapid optimized single antigen bead (ROB) assay protocol for LABScreen.
Hum Immunol Volume: 78 Page(s): 489 - 499
01/01/2017 Authors: Liwski RS; Greenshields AL; Murphey C; Bray RA; Gebel HM -
Kidney Transplantation of the Highly Sensitized Candidate: So Close But So Far Away
Volume: 17 Page(s): 51 - 51
01/01/2017 Authors: Parsons R; Decker H; Gebel H; Bray R -
REDUCED INCIDENCE AND LEVEL OF DE NOVO DONOR-SPECIFIC ANTIBODIES IN BELATACEPT-TREATED VS. CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT
TRANSPLANT INTERNATIONAL Volume: 29 Page(s): 11 - 12
10/01/2016 Authors: Bray R; Gebel H; Townsend R; Polinsky M; Yang L; Meier-Kriesche U; Larsen C -
Factors associated with successful downregulation of anti-HLA antibodies in heart transplant candidates.
Volume: 36 Page(s): E126 - E126
07/01/2016 Authors: Ellis M; Ingemi A; Palmer B; McRacken T; Landsheft H; Gebel H; Bray R -
A Pathway to Belatacept Monotherapy: Alemtuzumab, Belatacept and Rapamycin for Kidney Transplantation.
Volume: 16 Page(s): 303 - 303
06/01/2016 Authors: Guasch A; Xu H; Mehta A; Ghali A; Mead S; Gebel H; Bray R; Larsen C; Pearson T; Kirk A -
Reduced Incidence and Level of De Novo Donor-Specific Antibodies in Belatacept-Treated vs. Cyclosporine-Treated Patients: Final Results from BENEFIT.
Volume: 16 Page(s): 742 - 742
06/01/2016 Authors: Bray R; Gebel H; Townsend R; Polinsky M; Yang L; Meier-Kriesche U; Larsen C -
Virtual Crossmatching Under the New KAS: Safely Bypassing a Physical Crossmatch When Allocating Kidneys to Highly Sensitized Candidates.
Volume: 16 Page(s): 624 - 624
06/01/2016 Authors: Bray R; Parsons R; Turgeon N; Gebel H -
Survey Results Show Strong Support for Allowing Patients Undergoing Desensitization to Keep Their Pre-Desensitization CPRA Allocation Priority
Volume: 16 Page(s): 437 - 437
06/01/2016 Authors: Kucheryavaya A; Bray R; Tyan D -
Class I and II HLA antibodies in pediatric patients with thalassemia major.
Transfusion Volume: 56 Page(s): 878 - 884
04/01/2016 Authors: Yee MEM; Shah A; Anderson AR; Boudreaux J; Bray RA; Gebel HM; Josephson CD -
Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies.
Clin J Am Soc Nephrol Volume: 11 Page(s): 505 - 511
03/07/2016 Authors: Gebel HM; Kasiske BL; Gustafson SK; Pyke J; Shteyn E; Israni AK; Bray RA; Snyder JJ; Friedewald JJ; Segev DL -
LONG-TERM SURVIVAL OUTCOMES IN BELATACEPT-TREATED VS CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT-EXT
TRANSPLANT INTERNATIONAL Volume: 29 Page(s): 8 - 8
02/01/2016 Authors: Durrbach A; Bray R; Gebel H; Florman S; Kuypers D; Larsen CP; Pestana JM; Del Carmen Rial M; Rostaing L; Wekerle T -
BELATACEPT-TREATED PATIENTS HAD SUPERIOR GRAFT SURVIVAL COMPARED WITH CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT
TRANSPLANT INTERNATIONAL Volume: 29 Page(s): 8 - 8
02/01/2016 Authors: Vincenti F; Bray R; Gebel H; Grinyo J; Moal MC; Rice K; Rostaing L; Steinberg S; Meier-Kriesche U; Polinsky M -
CORRELATION BETWEEN FLOWPRA (R) AND LABSCREEN CLASS II SINGLE ANTIGEN BEADS FOR THE DETECTION OF HLA DQB ANTIBODIES: NOT ALL ASSAYS ARE CREATED EQUAL
Volume: 77 Page(s): 125 - 125
01/01/2016 Authors: Brannon P; Sutherland N; Marcus-Freeman N; Gebel H; Bray R -
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors
TRANSPLANTATION Volume: 100 Page(s): 194 - 202
01/01/2016 Authors: Freedman BI; Pastan SO; Israni AK; Schladt D; Julian BA; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD -
Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes.
PLoS One Volume: 11 Page(s): e0152775
01/01/2016 Authors: Dorr CR; Freedman BI; Hicks PJ; Brown WM; Russell GB; Julian BA; Pastan SO; Gautreaux MD; Muthusamy A; Chinnakotla S -
Belatacept-Treated Patients Had Superior Graft Survival vs. Cyclosporine-Treated Patients: Final Results From BENEFIT F
AMERICAN JOURNAL OF TRANSPLANTATION Volume: 16 Page(s): 44 - 44
01/01/2016 Authors: Vincenti F; Grinyo J; Bray R; Rostaing L; Bresnahan B; Rice K; Steinberg S; Gebel H; Polinsky M; Meier-Kriesche U -
Long-Term Survival Outcomes in Belatacept-Treated vs. Cyclosporine-Treated Patients: Final Results From BENEFIT-EXT
AMERICAN JOURNAL OF TRANSPLANTATION Volume: 16 Page(s): 45 - 45
01/01/2016 Authors: Florman S; Bray R; Gebel H; Kuypers D; Larsen C; Medina Pestana J; Rial M; Rostaing L; Wekerle T; Grannas G -
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
Transplantation Volume: 100 Page(s): 194 - 202
01/01/2016 Authors: Freedman BI; Pastan SO; Israni AK; Schladt D; Julian BA; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD -
Belatacept-treated patients had superior graft survival compared with cyclosporine-treated patients: final results from BENEFIT
Volume: 145 Page(s): 10S - 11S
11/12/2015 Authors: Vincenti F; Bray R; Gebel H; Grinyo J; Moal M-C; Rice K; Rostaing L; Steinberg S; Meier-Kriesche U; Polinsky M -
Long-term survival outcomes in belatacept-treated vs cyclosporine-treated patients: final results from BENEFIT-EXT
Volume: 145 Page(s): 41S - 41S
11/12/2015 Authors: Durrbach A; Bray R; Gebel H; Florman S; Kuypers D; Larsen CP; Pestana JM; Del Carmen Rial M; Rostaing L; Wekerle T -
DONOR-SPECIFIC ANTIBODY RATES ACROSS 7 YEARS OF TREATMENT WITH BELATACEPT: FINAL RESULTS FROM BENEFIT
TRANSPLANT INTERNATIONAL Volume: 28 Page(s): 242 - 242
11/01/2015 Authors: Meier-Kriesche H-U; Bray R; Gebel H; Townsend R; Larsen C -
EVALUATION OF DONOR-SPECIFIC ANTIBODIES THROUGH 7 YEARS WITH BELATACEPT: FINAL RESULTS FROM BENEFIT-EXT
TRANSPLANT INTERNATIONAL Volume: 28 Page(s): 82 - 82
11/01/2015 Authors: Meier-Kriesche H-U; Bray R; Gebel H; Townsend R; Larsen C -
BELATACEPT PATIENTS HAD SUPERIOR GRAFT SURVIVAL COMPARED WITH CYCLOSPORINE PATIENTS: FINAL RESULTS FROM BENEFIT
TRANSPLANT INTERNATIONAL Volume: 28 Page(s): 10 - 10
10/01/2015 Authors: Vincenti F; Bray R; Gebel H; Grinyo J; Moal M-C; Rice K; Rostaing L; Steinberg S; Meier-Kriesche U; Polinsky M -
LONG-TERM SURVIVAL OUTCOMES IN BELATACEPT-TREATED VS. CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT-EXT
TRANSPLANT INTERNATIONAL Volume: 28 Page(s): 10 - 10
10/01/2015 Authors: Durrbach A; Bray R; Gebel H; Florman S; Kuypers D; Larsen CP; Pestana JM; del Carmen Rial M; Rostaing L; Wekerle T -
High-Resolution HLA Typing for Sensitized Patients: Advances in Medicine and Science Require Us to Challenge Existing Paradigms.
Am J Transplant Volume: 15 Page(s): 2780 - 2781
10/01/2015 Authors: Duquesnoy RJ; Gebel HM; Woodle ES; Nickerson P; Baxter-Lowe LA; Bray RA; Claas FHJ; Eckels DD; Friedewald JJ; Fuggle SV -
Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation.
Kidney Int Volume: 88 Page(s): 584 - 592
09/01/2015 Authors: Ma J; Divers J; Palmer ND; Julian BA; Israni AK; Schladt D; Pastan SO; Chattrabhuti K; Gautreaux MD; Hauptfeld V -
Tacrolimus to Belatacept Conversion Following Hand Transplantation: A Case Report.
Am J Transplant Volume: 15 Page(s): 2250 - 2255
08/01/2015 Authors: Cendales L; Bray R; Gebel H; Brewster L; Elbein R; Farthing D; Song M; Parker D; Stillman A; Pearson T -
Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.
Br J Haematol Volume: 170 Page(s): 247 - 256
07/01/2015 Authors: Nickel RS; Hendrickson JE; Yee MM; Bray RA; Gebel HM; Kean LS; Miklos DB; Horan JT -
Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.
Am J Transplant Volume: 15 Page(s): 1615 - 1622
06/01/2015 Authors: Freedman BI; Julian BA; Pastan SO; Israni AK; Schladt D; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD -
Evaluation of Donor-Specific Antibodies Through 7 Years With Belatacept in BENEFIT and BENEFIT-EXT
Volume: 15
05/01/2015 Authors: Bray R; Gebel H; Townsend R; Meier-Kriesche U; Larsen C -
CPRA Values Are Substantially Increased for Some Candidates Subsequent to Inclusion of Unacceptable C-locus (UA-C) Antigens While Listing Practices Remain Unchanged
Volume: 15
05/01/2015 Authors: Kucheryavaya A; Bray R; Miller A; Tyan D -
Deceased Donor Kidney Transplantation Without Calcineurin Inhibitors or Steroids
Volume: 15
05/01/2015 Authors: Kirk A; Guasch A; Mead S; Ghali A; Mehta A; Gebel H; Bray R; Larsen C; Pearson T -
Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level?
Am J Transplant Volume: 15 Page(s): 923 - 930
04/01/2015 Authors: Duquesnoy RJ; Kamoun M; Baxter-Lowe LA; Woodle ES; Bray RA; Claas FHJ; Eckels DD; Friedewald JJ; Fuggle SV; Gebel HM -
IMPORTANCE OF ROUTINE COMPARISONS BETWEEN LUMINEX INSTRUMENTS WITHIN A SINGLE LABORATORY
Volume: 76 Page(s): 87 - 87
01/01/2015 Authors: Muchhala M; Wilmoth-Hosey L; Marcus-Freeman N; Gebel HM; Bray RA -
HLA-DPB1*ANTIGEN FREQUENCIES IN DECEASED DONORS: MINING THE DATA.
Volume: 76 Page(s): 26 - 26
01/01/2015 Authors: Karas A; Marcus-Freeman N; Breitenbach C; McRacken TT; Bray RA; Gebel H -
DIGGING DEEP: IDENTIFICATION OF A HIDDEN CROSSOVER
Volume: 76 Page(s): 86 - 86
01/01/2015 Authors: Weingard P; Marcus-Freeman N; Bray RA; Gebel HM -
ALLELIC ANTIBODIES AND THEIR IMPACT ON ORGAN ALLOCATION TO HIGHLY SENSITIZED PATIENTS
Volume: 76 Page(s): 61 - 61
01/01/2015 Authors: Iwakoshi NN; Bray RA; Gebel HM -
COMPUTER ASSISTED ALGORITHM FOR ASSESSING HLA DPB1 DONOR:RECIPIENT COMPATIBILITY.
Volume: 76 Page(s): 25 - 25
01/01/2015 Authors: Smith GH; Gebel HM; Bray RA -
INCREASED RELIANCE ON THE VIRTUAL CROSSMATCH UNDER THE NEW KIDNEY ALLOCATION SCHEMA (KAS)
Volume: 76 Page(s): 6 - 6
01/01/2015 Authors: Parsons RF; Gebel HM; Turgeon NA; Bray RA -
EVALUATION OF DONOR-SPECIFIC ANTIBODIES THROUGH 5 YEARS WITH BELATACEPT IN BENEFIT AND BENEFIT-EXT
TRANSPLANT INTERNATIONAL Volume: 28 Page(s): 7 - 7
01/01/2015 Authors: Meier-Kriesche U; Bray R; Gebel H; Brannon P; Ganguly B; Townsend R; Harler MB; Larsen C -
The new OPTN kidney allocation policy: potential for inequitable access among highly sensitized patients.
Am J Transplant Volume: 15 Page(s): 284 - 285
01/01/2015 Authors: Bray RA; Brannon P; Breitenbach C; Bryan C; Chen D-F; Lai J; McRacken T; Kirk A; Kaplan B; Pearson T -
The new kidney allocation system (KAS) and the highly sensitized patient: expect the unexpected.
Am J Transplant Volume: 14 Page(s): 2917
12/01/2014 Authors: Bray RA; Gebel HM -
Analysis of graft survival in a trial of stem cell transplant in ALS.
Ann Clin Transl Neurol Volume: 1 Page(s): 900 - 908
11/01/2014 Authors: Tadesse T; Gearing M; Senitzer D; Saxe D; Brat DJ; Bray R; Gebel H; Hill C; Boulis N; Riley J -
Solid-phase assays for the detection of alloantibody against human leukocyte antigens: panacea or Pandora?
Int J Immunogenet Volume: 41 Page(s): 362 - 369
10/01/2014 Authors: Roberts T; Tumer G; Gebel HM; Bray RA -
HLA antibody detection with solid phase assays: great expectations or expectations too great?
Am J Transplant Volume: 14 Page(s): 1964 - 1975
09/01/2014 Authors: Gebel HM; Bray RA -
Tacrolimus to Belatacept Conversion Following Hand Transplantation: A Case Report.
Volume: 98 Page(s): 410 - 410
07/15/2014 Authors: Cendales L; Bray R; Gebel H; Brewster L; Elbein R; Song M; Parker D; Stillman A; Pearson T; Kirk A -
Evaluation of Donor-Specific Antibodies Through 5 Years With Belatacept in BENEFIT and BENEFIT-EXT.
Volume: 98 Page(s): 117 - 117
07/15/2014 Authors: Bray R; Gebel H; Brannon P; Ganguly B; Townsend R; Meier-Kriesche U; Harler M; Larsen C -
Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept
Volume: 98 Page(s): 80 - 80
07/15/2014 Authors: Kirk A; Guasch A; Xu H; Cheeseman J; Mead S; Ghali A; Mehta A; Gebel H; Bray R; Horan J -
Pronase Treatment Reduces Denatured HLA Antigen On Single Antigen Beads (SABs)
Volume: 98 Page(s): 443 - 444
07/15/2014 Authors: Roberts T; Tumer G; Gebel H; Bray R -
Pronase Treatment Reduces Denatured HLA Antigen On Single Antigen Beads (SABs)
Volume: 14 Page(s): 443 - 444
06/01/2014 Authors: Roberts T; Tumer G; Gebel H; Bray R -
Evaluation of Donor-Specific Antibodies Through 5 Years With Belatacept in BENEFIT and BENEFIT-EXT
Volume: 14 Page(s): 117 - 117
06/01/2014 Authors: Bray R; Gebel H; Brannon P; Ganguly B; Townsend R; Meier-Kriesche U; Harler M; Larsen C -
Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept
Volume: 14 Page(s): 80 - 80
06/01/2014 Authors: Kirk A; Guasch A; Xu H; Cheeseman J; Mead S; Ghali A; Mehta A; Gebel H; Bray R; Horan J -
Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.
Am J Transplant Volume: 14 Page(s): 1142 - 1151
05/01/2014 Authors: Kirk AD; Guasch A; Xu H; Cheeseman J; Mead SI; Ghali A; Mehta AK; Wu D; Gebel H; Bray R -
Alloantibodies, Sensitization and Virtual Crossmatching
Page(s): 443 - 451
01/01/2014 Authors: Gebel HM; Bray RA -
KEEP IT COOL. A NOVEL INHIBITOR COMPLEX EXCLUSION (ICE) PROTOCOL FOR LABSCREEN THAT PREVENTS THE "PROZONE" EFFECT.
Volume: 75 Page(s): 7 - 7
01/01/2014 Authors: Liwski R; Bray R; Gebel H -
Monitoring for HLA Antibody after Organ Transplantation
Page(s): 1059 - 1064
01/01/2014 Authors: Bray RA; Gebel HM -
PRONASE TREATMENT OF SINGLE ANTIGEN BEADS (SAB) REVEALS A COMPLEX BIOLOGY FOR EXPLAINING DENATURED HLA ANTIGENS.
Volume: 75 Page(s): 66 - 66
01/01/2014 Authors: Roberts TK; Turner G; Bray RA; Gebel HM -
A BIOTIN/STREPTAVIDIN ENHANCED SINGLE ANTIGEN BEAD (SAB) METHOD IMPROVES SENSITIVITY AND OVERCOMES COMPLEMENT MEDIATED INHIBITION.
Volume: 75 Page(s): 66 - 66
01/01/2014 Authors: Roberts TK; Tinckam K; Turner G; Gebel HM; Bray RA -
THE NEW OPTN KIDNEY ALLOCATION POLICY: INEQUITBLE ACCESS AMONG HIGHLY SENSITIZED PATIENTS.
Volume: 75 Page(s): 30 - 30
01/01/2014 Authors: Bray R; Brannon P; Breitenbach C; McRacken T; Stephens M; Lai J; Mui E; Gebel H -
IT'S ABOUT TIME. THE DEVELOPMENT OF THE RAPID OPTIMIZED SINGLE ANTIGEN BEAD (ROB) LABSCREEN (R) PROTOCOL TO EXPEDITE HLA ANTIBODY TESTING.
Volume: 75 Page(s): 7 - 7
01/01/2014 Authors: Liwski R; Neumann J; Peladeau G; Heinstein K; Sperry R; Bray R; Gebel H -
Influence of race/ethnic differences in pre-transplantation panel reactive antibody on outcomes in heart transplant recipients.
Volume: 62 Page(s): 2308 - 2315
12/17/2013 Authors: Morris AA; Cole RT; Veledar E; Bellam N; Laskar SR; Smith AL; Gebel HM; Bray RA; Butler J -
Alloimmunization To HLA Class I Antigens But Not H-Y Antigens Is Associated With Transfusion In Children With Sickle Cell Disease
Volume: 122
11/15/2013 Authors: Nickel RS; Hendrickson JE; Kean LS; Yee MEM; Bray RA; Gebel HM; Miklos DB; Horan JT -
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation.
Am J Transplant Volume: 13 Page(s): 3050 - 3051
11/01/2013 Authors: Reed EF; Rao P; Zhang Z; Gebel H; Bray RA; Guleria I; Lunz J; Mohanakumar T; Nickerson P; Tambur AR -
Conundrums With Solid Phase HLA Antibody Testing
Volume: 140 Page(s): 420 - 420
09/01/2013 Authors: Tumer G; Roberts-Wilson T; Gebel HM; Bray RA; Hill CE -
"In Control" in the HLA Laboratory: Using QC to Improve Consistency and Efficiency
Volume: 140 Page(s): 420 - 420
09/01/2013 Authors: Roberts-Wilson TK; Tumer G; Bray RA; Gebel HM; Fantz CR -
Technical aspects of HLA antibody testing.
Curr Opin Organ Transplant Volume: 18 Page(s): 455 - 462
08/01/2013 Authors: Gebel HM; Liwski RS; Bray RA -
In search of perfection.
Am J Transplant Volume: 13 Page(s): 1951 - 1952
08/01/2013 Authors: Gebel HM; Bray RA -
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.
Am J Transplant Volume: 13 Page(s): 1859 - 1870
07/01/2013 Authors: Reed EF; Rao P; Zhang Z; Gebel H; Bray RA; Guleria I; Lunz J; Mohanakumar T; Nickerson P; Tambur AR -
UNEXPLAINED POSITIVE REACTIONS WITH ONE LAMBDA, FLOWPRA (TM) LOT #18
Volume: 74 Page(s): 486 - 486
05/01/2013 Authors: Bray RA; McLachlan L; Chapman P; Marcus N; Gebel HM -
Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
Am J Transplant Volume: 13 Page(s): 954 - 960
04/01/2013 Authors: O'Leary JG; Gebel HM; Ruiz R; Bray RA; Marr JD; Zhou XJ; Shiller SM; Susskind BM; Kirk AD; Klintmalm GB -
Gradual vs Rapid Withdrawal of Immunosuppression after Kidney Allograft Failure Results in Less Allosensitization, Decreased Rate of De-Novo Donor Specific Antibody and Reduced Need for Allograft Nephrectomy.
Volume: 13 Page(s): 472 - 472
04/01/2013 Authors: Rao S; Bray R; Perez S; Pastan S; Gebel H; Chami A -
HLA-DR Mismatching Is Not Associated with Decreased Graft Survival in Highly Sensitized Kidney Recipients.
Volume: 13 Page(s): 420 - 420
04/01/2013 Authors: Ruhil R; Talebagha S; Beus J; Pearson T; Gebel H; Bray R; Turgeon N -
Utility of Whole Slide Imaging Algorithms in the Assessment of Renal Allograft Biopsies: Does Automated Analysis Provide a Better Assessment of Donor Specific Antibody Than Human Scoring?
Volume: 93 Page(s): 393A - 394A
02/01/2013 Authors: Stuart LN; Tumer G; Roberts-Wilson T; Gebel HM; Bray RA; Farris AB -
Utility of Whole Slide Imaging Algorithms in the Assessment of Renal Allograft Biopsies: Does Automated Analysis Provide a Better Assessment of Donor Specific Antibody Than Human Scoring?
Volume: 26 Page(s): 393A - 394A
02/01/2013 Authors: Stuart LN; Tumer G; Roberts-Wilson T; Gebel HM; Bray RA; Farris AB -
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
Transplantation Volume: 95 Page(s): 19 - 47
01/15/2013 Authors: Tait BD; Ssal C; Gebel HM; Nickerson PW; Zachary AA; Claas FHJ; Reed EF; Bray RA; Campbell P; Chapman JR -
INTERFERING FACTORS INTERFERE WITH VIRTUAL CROSSMATCH (vXM) INTERPRETATION.
Volume: 74 Page(s): 70 - 70
01/01/2013 Authors: McRacken TT; Keatley K; Stephens M; Hogan K; Spraggins C; Zannini A; Fortes W; Phelps E; Bray RA; Gebel HM -
PRETREATMENT OF PATIENT SERUM WITH FETAL BOVINE SERUM (FBS) REDUCES NON-SPECIFIC BACKGROUND AND ENHANCES HLA ANTIBODY DETECTION IN BEAD AND CELL BASED ASSAYS
Volume: 74 Page(s): 57 - 57
01/01/2013 Authors: Breitenbach C; Kaelin L; Chapman P; Gebel HM; Bray RA -
Lymphocyte crossmatching by flow cytometry.
Methods Mol Biol Volume: 1034 Page(s): 285 - 296
01/01/2013 Authors: Bray RA -
NO DIRECT CORRELATION BETWEEN DONOR SPECIFIC ANTIBODY (DSA) MEAN FLUORESCENCE INTENSITY (MFI) AND C4d POSITIVITY IN ANTIBODY MEDIATED REJECTION (AMR).
Volume: 74 Page(s): 98 - 98
01/01/2013 Authors: Tumer G; Roberts-Wilson TK; Alton FB; Lauren SN; Gebel HM; Bray RA -
IMPACT OF VARYING MFI THRESHOLDS ON CPRA VALUES AND ACCESS TO DECEASED DONOR ORGANS.
Volume: 74 Page(s): 68 - 68
01/01/2013 Authors: Lai J; Mui E; Eckels D; Gebel H; Bry W; Katznelson S; Patel P; Bray R -
FATAL GRAFT VERSUS HOST DISEASE (GVHD) AFTER ZERO MISMATCH KIDNEY/PANCREAS TRANSPLANTATION.
Volume: 74 Page(s): 21 - 21
01/01/2013 Authors: Tumer G; Roberts-Wilson TK; Bray RA; Gebel HM -
ONE IS NOT ENOUGH: POTENTIAL IMPACT OF DISCONNECTS BETWEEN SOLID-PHASE ASSAYS.
Volume: 74 Page(s): 168 - 168
01/01/2013 Authors: Roberts-Wilson TK; Turner G; Gebel HM; Bray RA -
THE ANTI-HUMAN GLOBULIN ENHANCED C1QSCREEN (TM) ASSAY IMPROVES THE DETECTION OF COMPLEMENT BINDING DONOR SPECIFIC HLA ANTIBODIES
Volume: 74 Page(s): 48 - 48
01/01/2013 Authors: Liwski R; Lee S; Sperry R; Nickerson P; Bray R; Gebel H -
QUALITY CONTROL IN THE HLA LABORATORY: THE EFFECT OF INTER-ASSAY VARIABILITY ON SINGLE ANTIGEN BEAD ASSAYS (SABs).
Volume: 74 Page(s): 95 - 95
01/01/2013 Authors: Roberts-Wilson TK; Turner G; Bray RA; Gebel HM -
Cross Validation of Luminex Platforms from Two Vendors to Detect and Quantify HLA Antibodies Using Single Antigen Assay Results from 7 CTOT Core Laboratories
Volume: 94 Page(s): 198 - 198
11/27/2012 Authors: Reed E; Rao P; Zhang Z; Gebel H; Bray R; Guleria I; Mohanakumar T; Nickerson P; Tambur A; Zeevi A -
Translational applications of flow cytometry in clinical practice.
J Immunol Volume: 188 Page(s): 4715 - 4719
05/15/2012 Authors: Jaye DL; Bray RA; Gebel HM; Harris WAC; Waller EK -
A Retrospective Analysis of 10 Years of Acceptable Mismatching of HLA Antigens in Deceased Donor Kidney Transplantation
Volume: 12 Page(s): 420 - 421
05/01/2012 Authors: Ruhil R; Beus J; Pearson T; Gebel H; Bray R; Turgeon N -
Revisiting Acceptable Mismatching of HLA Antigens: Transplanting Highly Sensitized Patients
Volume: 12 Page(s): 416 - 416
05/01/2012 Authors: Bray R; Ruhil R; Beus J; Pearson T; Turgeon N; Gebel H -
Preformed MHC Class II Antibodies Increase the Risk of Liver but Not Kidney Rejection after Simultaneous Liver-Kidney Transplant.
Volume: 18 Page(s): S92 - S92
05/01/2012 Authors: O'Leary JG; Gebel HM; Ruiz RM; Bray RA; Marr JD; Susskind BM; Kirk AD; Klintmalm GB -
HEAT SENSTIVE "INTERFERING FACTOR" MASKS THE POST TRANSPLANT DETECTION OF DE NOVO DONOR SPECIFIC ANTIBODY
Volume: 73 Page(s): 93 - 93
01/01/2012 Authors: McRacken TT; Spraggins CM; Gebel HM; Bray RA -
VALIDATION OF THE LUMINEX PLATFORM TO DETECT HLA ANTIBODIES: EFFECT OF STANDARDIZING OPERATION PROCEDURES ON TEST VARIABILITY BY CTOT CORE LABORATORIES
Volume: 73 Page(s): 25 - 25
01/01/2012 Authors: Rao P; Zhang Z; Gebel H; Bray RA; Guleria I; Mohanakumar T; Nickerson P; Tambur A; Zeevi A; Heeger P -
Revisiting traditional risk factors for rejection and graft loss after kidney transplantation.
Am J Transplant Volume: 11 Page(s): 2132 - 2143
10/01/2011 Authors: Dunn TB; Noreen H; Gillingham K; Maurer D; Ozturk OG; Pruett TL; Bray RA; Gebel HM; Matas AJ -
EVALUATION OF DONOR-SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANT PATIENTS TREATED WITH BELATACEPT- OR CYCLOSPORINE-BASED IMMUNOSUPPRESSION IN BENEFIT AND BENEFIT-EXT
TRANSPLANT INTERNATIONAL Volume: 24 Page(s): 69 - 69
09/01/2011 Authors: Larsen CP; Bray R; Gebel H; Ganguly B; Kulbokas E; Brickman D; Duan T; Townsend R -
Luminex MFI values do not correlate with flow cytometry crossmatch (FCXM) results in patients with low levels of HLA antibodies directed against the public epitopes BW4 AND BW6
Volume: 77 Page(s): 444 - 444
05/01/2011 Authors: Moussa O; Waslaske SH; Thompson T; Marchman CG; Bray RA; Gebel HM -
Calculated PRA: a process whose time has come or 'Dj vu' all over again?
Am J Transplant Volume: 11 Page(s): 650 - 651
04/01/2011 Authors: Bray RA; Murphey C; Schaub S -
Antibody Mediated Rejection in Kidney Transplant Recipients with and without Donor Specific Antibodies.
Volume: 11 Page(s): 297 - 297
04/01/2011 Authors: Miguel M; Lai J; Bray R; Eckels D; Gebel H; Bry W; Katznelson S; Peddi VR -
Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants.
Am J Transplant Volume: 11 Page(s): 841 - 847
04/01/2011 Authors: Dar W; Agarwal A; Watkins C; Gebel HM; Bray RA; Kokko KE; Pearson TC; Knechtle SJ -
Paired kidney donation: a (virtual) balancing act.
Am J Transplant Volume: 11 Page(s): 194 - 195
02/01/2011 Authors: Bingaman AW; Bray RA; Gebel HM; Newell KA -
HLA-DR Immunohistochemistry Quantitation in Renal Allograft Biopsies: Objective Discrimination of Rejection and Other Pathologic Processes.
Volume: 24 Page(s): 344A - 344A
02/01/2011 Authors: Farris AB; Kong J; Chisolm C; Gebel HM; Bray RA; Cohen C; Brat DJ; Saltz JH; Kirk AD; Hennigar R -
HLA-DR Immunohistochemistry Quantitation in Renal Allograft Biopsies: Objective Discrimination of Rejection and Other Pathologic Processes
Volume: 91 Page(s): 344A - 344A
02/01/2011 Authors: Farris AB; Kong J; Chisolm C; Gebel HM; Bray RA; Cohen C; Brat DJ; Saltz JH; Kirk AD; Hennigar R -
IDENTIFICATION OF DENATURED CLASS II (DRB4) ANTIGENS ON SINGLE ANTIGEN BEADS
Volume: 72 Page(s): S20 - S20
01/01/2011 Authors: Bray RA; Gebel HM; Lee J -
Clinical cytometry and progress in HLA antibody detection.
Methods Cell Biol Volume: 103 Page(s): 285 - 310
01/01/2011 Authors: Bray RA; Tarsitani C; Gebel HM; Lee J-H -
SINGLE ANTIGEN BEADS REACH SATURATION AT ANTIBODY LEVELS THAT DO NOT SATURATE LYMPHOCYTES IN THE FLOW CYTOMETRIC CROSSMATCH
Volume: 72 Page(s): S21 - S21
01/01/2011 Authors: Bray RA; Coleman LA; Brannon PE; Gebel HM -
SEROLOGICAL EVIDENCE FOR THREE DISTINCT SUB-EPITOPES OF Bw6
Volume: 72 Page(s): S22 - S22
01/01/2011 Authors: Bray RA; Gebel HM -
SHOULD CONFIRMATORY HLA TYPING BE MANDATORY?
Volume: 72 Page(s): S151 - S151
01/01/2011 Authors: Breitenbach C; Bray RA; Gebel HM -
THE IMPORTANCE OF IDENTIFYING WEAK DSA AT THE TIME OF TRANSPLANT IN THE FACE OF A NEGATIVE CROSSMATCH.
Volume: 72 Page(s): S155 - S155
01/01/2011 Authors: McRacken TT; Bray RA; Gebel HM; Stephens MS; Kalmanovich Y -
AN OPTIMIZED FLOW CYTOMETRIC CROSSMATCH ASSAY EXPEDITES PRE-TRANSPLANT IMMUNOLOGIC RISK ASSESSMENT
Volume: 72 Page(s): S48 - S48
01/01/2011 Authors: Liwski R; Adams G; Peladeau G; Eckels D; Bray R; Gebel H -
PREDICTING CROSSMATCH RESULTS BASED ON LUMINEX MFI VALUES: GREAT EXPECTATIONS OR EXPECTATIONS TOO GREAT?
Volume: 72 Page(s): S32 - S32
01/01/2011 Authors: Gebel HM; Bray RA -
The evolution and clinical impact of human leukocyte antigen technology.
Curr Opin Nephrol Hypertens Volume: 19 Page(s): 598 - 602
11/01/2010 Authors: Gebel HM; Bray RA -
Overcoming HLA-DPB1 donor specific antibody-mediated haematopoietic graft failure.
Br J Haematol Volume: 151 Page(s): 94 - 96
10/01/2010 Authors: Costa LJ; Moussa O; Bray RA; Stuart RK -
A novel Luminex based detection method for IgG subclass specification of anti-HLA antibodies
Volume: 75 Page(s): 577 - 577
05/01/2010 Authors: Ozturk OG; Bray R; Gebel H -
Impact of Desensitization on Donor Sensitized, AHG XM Negative Kidney Transplants
Volume: 10 Page(s): 225 - 226
04/01/2010 Authors: Dunn TB; Noreen HJ; Maurer D; Ozturk OG; Gillingham K; Bray R; Gebel H; Matas AJ -
Impact of Flow XM Results on Kidney Transplant Outcomes for Recipients with Donor Specific Antibody (DSA).
Volume: 10 Page(s): 236 - 236
04/01/2010 Authors: Dunn TB; Ozturk OG; Noreen H; Maurer D; Gillingham K; Bray RA; Matas AJ; Gebel HM -
The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure.
Blood Volume: 115 Page(s): 2704 - 2708
04/01/2010 Authors: Spellman S; Bray R; Rosen-Bronson S; Haagenson M; Klein J; Flesch S; Vierra-Green C; Anasetti C -
Liver Transplantation Removes MHC Class I but Not Class II Antibody from Sensitized Recipients of Combined Liver/Kidney Transplants.
Volume: 10 Page(s): 100 - 100
04/01/2010 Authors: Agarwal A; Gebel HM; Bray RA; Watkins C; Kokko KE; Pearson TC; Knechtle SJ -
HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.
Pediatr Blood Cancer Volume: 54 Page(s): 552 - 558
04/01/2010 Authors: McPherson ME; Anderson AR; Castillejo M-I; Hillyer CD; Bray RA; Gebel HM; Josephson CD -
IMPACT OF LOW LEVEL DONOR SPECIFIC ANTIBODIES IN RENAL TRANSPLANT OUTCOMES
Volume: 71 Page(s): S25 - S25
01/01/2010 Authors: Dunn TB; Noreen H; Maurer D; Ozturk OG; Gillingham K; Matas AJ; Bray RA; Gebel HM -
DEFINING CUT-OFF FOR THE LUMINEX MFI THAT CAN PREDICT THE FLOW CYTOMETRIC CROSSMATCH (FCXM) RESULTS.
Volume: 71 Page(s): S46 - S46
01/01/2010 Authors: Moussa O; Gebel HM; Bray RA -
LUMINEX BASED DETECTION OF IgG SUBCLASSES IN HLA ALLOANTISERA
Volume: 71 Page(s): S98 - S98
01/01/2010 Authors: Ozturk OG; Bray RA; Gebel HM -
PLATELET REFRACTORY PATIENT WITH AN ALLELE SPECIFIC HLA ANTIBODY.
Volume: 71 Page(s): S122 - S122
01/01/2010 Authors: O'Shields AR; Cellars KA; Gates DA; Hagy C; McPherson EM; Thompson TG; Waslaski SH; Moussa O; Gebel HM; Bray RA -
DISCONNECT BETWEEN LUMINEX MFI AND FLOW CYTOMETRY CROSSMATCH (FCXM) RESULTS FOR Bw4 AND Bw6 ANTIBODIES.
Volume: 71 Page(s): S145 - S145
01/01/2010 Authors: Moussa O; Waslaski SH; Thompson T; O'Shields AR; Marchman CG; Bray RA; Gebel HM -
Proinflammatory events and HLA antibodies: nothing to sneeze at.
Am J Transplant Volume: 9 Page(s): 1971 - 1972
09/01/2009 Authors: Kokko KE; Bray RA; Nickerson PW; Gebel HM -
Donor-reactive HLA antibodies in renal allograft recipients: considerations, complications, and conundrums.
Hum Immunol Volume: 70 Page(s): 610 - 617
08/01/2009 Authors: Gebel HM; Moussa O; Eckels DD; Bray RA -
Strategies for human leukocyte antigen antibody detection.
Curr Opin Organ Transplant Volume: 14 Page(s): 392 - 397
08/01/2009 Authors: Bray RA; Gebel HM -
EVALUATION OF THE WHOLE GENOME AMPLIFICATION PROCEDURE IN ROUTINE HLA TYPING OF STEM CELLS TRANSPLANTATION CANDIDATES
Volume: 70 Page(s): S34 - S34
01/01/2009 Authors: Waslaske SH; Gates DA; Nasse CB; Bray RA; Gebel HM; Moussa O -
Positive Cross-Match Kidney Transplantation in a Non-Academic Transplant Program: Is It Feasible?
Volume: 9 Page(s): 561 - 561
01/01/2009 Authors: Pollinger H; Tan M; Wolf J; Johnson M; Sellers M; Cross R; Bray R; Gebel H; Zayas C; Whelchel J -
USE OF THE LUMINEX HDID BEADS FOR RAPID EVALUATION OF THE QUALITY OF POOLED POSITIVE CONTROL SERUM FOR THE USE IN FLOW CYTOMETRIC CROSSMATCH AND ANTIBODIES SCREENING ASSAYS
Volume: 70 Page(s): S33 - S33
01/01/2009 Authors: Waslaske SH; Marchman CG; McPherson EM; Francia JL; Bray RA; Gebel HM; Moussa O -
ANTIBODY-MEDIATED REJECTION WITH ANTI-HLA-DP ANTIBODIES IN A HLA IDENTICAL RENAL ALLOGRAFT
Volume: 70 Page(s): S142 - S142
01/01/2009 Authors: Halpin A; Sis B; Youngs D; Gebel H; Bray R; Campbell P -
Monitoring after renal transplantation: recommendations and caveats.
Nat Clin Pract Nephrol Volume: 4 Page(s): 658 - 659
12/01/2008 Authors: Bray RA; Gebel HM -
Cytotoxicity and antibody binding by flow cytometry: a single assay to simultaneously assess two parameters.
Cytometry B Clin Cytom Volume: 74 Page(s): 287 - 294
09/01/2008 Authors: Saw CL; Bray RA; Gebel HM -
National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants.
Biol Blood Marrow Transplant Volume: 14 Page(s): 45 - 53
09/01/2008 Authors: Bray RA; Hurley CK; Kamani NR; Woolfrey A; Mller C; Spellman S; Setterholm M; Confer DL -
HLA alloinimmunization in pediatric sickle cell disease patients: Potential impact for transfusion management
Volume: 48 Page(s): 54A - 54A
09/01/2008 Authors: McPherson M; Anderson A; Jessup P; Castillejo M-I; Bray R; Gebel H; Hillyer C; Josephson C -
Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry.
Biol Blood Marrow Transplant Volume: 14 Page(s): 37 - 44
09/01/2008 Authors: Spellman S; Setterholm M; Maiers M; Noreen H; Oudshoorn M; Fernandez-Via M; Petersdorf E; Bray R; Hartzman RJ; Ng J -
Approaches for transplanting the sensitized patient: biology versus pharmacology.
Nephrol Dial Transplant Volume: 23 Page(s): 2454 - 2457
08/01/2008 Authors: Gebel HM; Bray RA -
Combined liver-kidney transplantation across a positive flow crossmatch: A cause for concern?
Volume: 8 Page(s): 337 - 337
05/01/2008 Authors: Shen LY; Agarwal A; Turgeon NA; Larsen CP; Pearson TC; Bray RA; Gebel HM; Kirk AD; Kokko KE -
Relevance of donor specific antibodies in simultaneous liver kidney transplantation
Volume: 8 Page(s): 378 - 378
05/01/2008 Authors: Agarwal A; Shen LY; Kokko KE; Bray RA; Gebel HM; Pearson TC; Larsen CP; Kirk AD -
HLA ALLOIMMUNIZATION IN PEDIATRIC SICKLE CELL DISEASE.
Volume: 69 Page(s): S62 - S62
01/01/2008 Authors: McPherson ME; Anderson AR; Bray RA; Gebel HM; Josephson CD -
State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants.
Biol Blood Marrow Transplant Volume: 14 Page(s): 1 - 6
01/01/2008 Authors: Kamani N; Spellman S; Hurley CK; Barker JN; Smith FO; Oudshoorn M; Bray R; Smith A; Williams TM; Logan B -
The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure.
Volume: 110 Page(s): 146A - 146A
11/16/2007 Authors: Bray R; Rosen-Bronson S; Haagenson M; Klein J; Flesch S; Vierra-Green C; Spellman S; Anasetti C -
Evolution of molecular HLA typing and HLA antibody detection.
Volume: 72B Page(s): 115 - 116
03/01/2007 Authors: Bray RA; Gebel HM -
Cytotoxicity and antibody binding by flow cytometry: One assay to assess two parameters
Volume: 68 Page(s): S117 - S117
01/01/2007 Authors: Saw C; Bray RA; Heaney DL; Gebel HM -
Influence of HLA-C locus antigens in BK viremia
Volume: 68 Page(s): S15 - S15
01/01/2007 Authors: Mendel B; Newell K; Kokko K; Bray R; Gebel H -
Current UNET algorithm is inadequate for allocating organs to sensitized patients
Volume: 68 Page(s): S17 - S17
01/01/2007 Authors: Waslaske SH; Heaney DL; Gebel HG; Bray RA -
Improved detection of HLA antibodies by labscreen (R) single antigen using a Biotin-Streptavidin complex
Volume: 68 Page(s): S21 - S21
01/01/2007 Authors: Brannon P; Heaney DL; Marchman C; Waslaske S; Saw CL; Gebel HM; Bray RA -
Standardization of HLA antibody identification across multiple laboratories. Is it feasible?
Volume: 68 Page(s): S117 - S117
01/01/2007 Authors: Campbell P; Bray R; Eckels D; Gebel H -
Differential expression of HLA class I on B cell subsets
Volume: 67 Page(s): S10 - S10
10/01/2006 Authors: Saw C; Bray RA; Gebel HM -
LABScreen (R) Mixed vs. Flowpra (R) screen: Which is better for routine monitoring of HLA antibodies?
Volume: 67 Page(s): S76 - S76
10/01/2006 Authors: Heaney DL; Marchman CG; Waslaske SH; Eckels DD; Gebel HM; Bray RA -
Repeat/confirmatory HLA typing for stem cell patients; Recommendation or requirement?
Volume: 67 Page(s): S55 - S55
10/01/2006 Authors: Heaney DL; Waslaske SH; Eckels DD; Bray RA; Gebel HM -
Cytotoxicity screening in the era of solid phase HLA antibody detection assays: Is it necessary?
Volume: 67 Page(s): S68 - S68
10/01/2006 Authors: Holcomb JE; Gebel HM; Bray RA -
Transplanting the highly sensitized patient: The emory algorithm.
Am J Transplant Volume: 6 Page(s): 2307 - 2315
10/01/2006 Authors: Bray RA; Nolen JDL; Larsen C; Pearson T; Newell KA; Kokko K; Guasch A; Tso P; Mendel JB; Gebel HM -
Testing a new technology platform for typing HLA alleles (4-MAT (TM))
Volume: 67 Page(s): 557 - 557
06/01/2006 Authors: De Canck I; Mersch G; Dossche I; Adams P; Bray R; Gebel H; Parish G -
Identification of unrelated cord blood units for hematopoietic stem cell transplantation in children with sickle cell disease.
J Pediatr Hematol Oncol Volume: 28 Page(s): 29 - 32
01/01/2006 Authors: Adamkiewicz TV; Boyer MW; Bray R; Haight A; Yeager AM -
A fully-automated screening method for qnti-HLA antibodies: Implications for screening plasma donations to prevent transfusion-related acute lung injury (TRALI)
Volume: 106 Page(s): 282A - 282A
11/16/2005 Authors: Culler E; Barclay SB; Bray RA; Gebel HM; Hillyer CD; Roback JD -
Allele-specific HLA alloantibodies: Implicaitons for organ allocation.
Volume: 5 Page(s): 488 - 489
05/01/2005 Authors: Bray RA; Gebel HM -
Pra (predictive reactivity of alloantibody); A new approach for crossmatch prediction.
Volume: 5 Page(s): 489 - 489
05/01/2005 Authors: Bray RA; Gebel HM -
Comparable graft survival in sensitized and unsensitized renal transplant recipients: A 5 year single center review.
Volume: 5 Page(s): 456 - 456
05/01/2005 Authors: Nolen JDL; Gebel HM; Larsen C; Pearson T; Newell K; Kokko K; Guasch A; Tso P; Bray RA -
Identification of HLA class II antibody specificities in high PRA patients
Volume: 6 Page(s): S69 - S69
04/01/2005 Authors: Pei R; Shih R; Chen M; Bray R; Gebel H; Lee JH -
Masking of HLA antibodies by Thymoglobulin (R)
Volume: 66 Page(s): S12 - S12
01/01/2005 Authors: Gebel HM; Bunce M; Crosby I; Nolen JDL; Bray RA -
A 5 year single center review of graft survival in sensitized renal transplant recipients
Volume: 66 Page(s): S56 - S56
01/01/2005 Authors: Nolen JDL; Bray RA; Pearson T; Larsen C; Newell K; Kokko K; Guasch A; Tso P; Gebel HM -
Allele-specific HLA alloantibodies and implications for organ allocation
Volume: 66 Page(s): S10 - S10
01/01/2005 Authors: Bray RA; Gebel HM -
Pronase treatment facilitates alloantibody flow cytometric and cytotoxic crossmatching in the presence of rituximab.
Hum Immunol Volume: 65 Page(s): 803 - 809
08/01/2004 Authors: Bearden CM; Agarwal A; Book BK; Sidner RA; Gebel HM; Bray RA; Pescovitz MD -
Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
Transplantation Volume: 78 Page(s): 221 - 227
07/27/2004 Authors: Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD -
Unappreciated risk factors for transplant patients: HLA antibodies in blood components.
Hum Immunol Volume: 65 Page(s): 240 - 244
03/01/2004 Authors: Bray RA; Harris SB; Josephson CD; Hillyer CD; Gebel HM -
Flow cytometric assessment of HLA alloantibodies.
Curr Protoc Cytom Volume: Chapter 6 Page(s): Unit - 6.16
02/01/2004 Authors: Bray RA; Gebel HM; Ellis TM -
Adult reserve stem cells and their potential for tissue engineering.
Cell Biochem Biophys Volume: 40 Page(s): 1 - 80
01/01/2004 Authors: Young HE; Duplaa C; Romero-Ramos M; Chesselet M-F; Vourc'h P; Yost MJ; Ericson K; Terracio L; Asahara T; Masuda H -
Class II donor specific antibodies are pathogenic in primary renal allografts.
Volume: 4 Page(s): 257 - 257
01/01/2004 Authors: Nickerson P; Pochinco D; Karpinski M; Gebel H; Bray R; Gibson I; Rush D; Jeffery J -
Evolution of HLA antibody detection: technology emulating biology.
Immunol Res Volume: 29 Page(s): 41 - 54
01/01/2004 Authors: Bray RA; Nickerson PW; Kerman RH; Gebel HM -
Molecular HLA testing for routine typing of deceased donors
Volume: 65 Page(s): S90 - S90
01/01/2004 Authors: Gebel HM; Wilmoth-Hosey L; Holcomb JE; Chapman P; Bray RA -
Kidney transplantation following administration of high dose intravenous immunoglobulin in patients with positive flow cytometric/negative enhanced cytotoxicity crossmatch.
Volume: 4 Page(s): 256 - 256
01/01/2004 Authors: Gloor JM; Mai ML; DeGoey SR; Larson TS; Gonwa TA; Gebel HM; Bray RA; Moore SB; Genco PV; Stegall MD -
Identification of allele-specific HLA class II alloantibodies: Paradigm or paradox
Volume: 65 Page(s): S39 - S39
01/01/2004 Authors: Bray RA; Wilmoth-Hosey L; Chapman P; Holcomb JE; Gebel HM -
Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk.
Am J Transplant Volume: 3 Page(s): 1488 - 1500
12/01/2003 Authors: Gebel HM; Bray RA; Nickerson P -
Prevalence of HLA alloantibodies in blood components using a flow cytometry-based screening assay: Potential clinical implications.
Volume: 100 Page(s): 285A - 285A
11/16/2002 Authors: Harris SB; Gebel HM; Josephson CD; Hillyer CD; Bray RA -
Anti-CD40 therapy extends renal allograft survival in rhesus macaques.
Transplantation Volume: 74 Page(s): 933 - 940
10/15/2002 Authors: Pearson TC; Trambley J; Odom K; Anderson DC; Cowan S; Bray R; Lin A; Hollenbaugh D; Aruffo A; Siadak AW -
Discordance at human leukocyte antigen-DRB3 and protection from human immunodeficiency virus type 1 transmission.
J Infect Dis Volume: 185 Page(s): 1729 - 1735
06/15/2002 Authors: Hader SL; Hodge TW; Buchacz KA; Bray RA; Padian NS; Rausa A; Slaviniski SA; Holmberg SD -
Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development.
J Exp Med Volume: 195 Page(s): 1053 - 1062
04/15/2002 Authors: Chen X; Laur O; Kambayashi T; Li S; Bray RA; Weber DA; Karlsson L; Jensen PE -
Regulated HLA-DO expression during B cell development and the germinal center reaction
FASEB JOURNAL Volume: 16 Page(s): A704 - A704
03/20/2002 Authors: Chen XJ; Laur O; Kambayashi T; Li SY; Bray RA; Weber D; Kalsson L; Jensen PE -
Conundrums with FlowPRA beads.
Clin Transplant Volume: 16 Suppl 7 Page(s): 24 - 29
01/01/2002 Authors: Gebel HM; Harris SB; Zibari G; Bray RA -
Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors.
Anat Rec Volume: 264 Page(s): 51 - 62
09/01/2001 Authors: Young HE; Steele TA; Bray RA; Hudson J; Floyd JA; Hawkins K; Thomas K; Austin T; Edwards C; Cuzzourt J -
Flow cytometry in human leukocyte antigen testing.
Semin Hematol Volume: 38 Page(s): 194 - 200
04/01/2001 Authors: Bray RA -
Improved flow cytometric detection of HLA alloantibodies using pronase: potential implications in renal transplantation.
Transplantation Volume: 71 Page(s): 422 - 428
02/15/2001 Authors: Vaidya S; Cooper TY; Avandsalehi J; Barnes T; Brooks K; Hymel P; Noor M; Sellers R; Thomas A; Stewart D -
Low-resolution HLA class II typing for solid organ transplantation is inadequate.
Transplant Proc Volume: 33 Page(s): 500
01/01/2001 Authors: Bray RA; Gebel HM -
Allele-specific alloantibodies identified with flow-specific PRA (TM) microparticles.
Page(s): 3 - 4
01/01/2001 Authors: Bray RA; Holcomb J; Chapman P; Jones H -
Preliminary evaluation of the luminex LABMAS (TM) system for the detection of HLA class II antibodies
Page(s): 7 - 8
01/01/2001 Authors: Bray RA; Chapman P; Jones H; Holcomb J -
Flow PRA to detect clinically relevant HLA antibodies.
Transplant Proc Volume: 33 Page(s): 477
01/01/2001 Authors: Gebel HM; Bray RA; Ruth JA; Zibari GB; McDonald JC; Kahan BD; Kerman RH -
Pronase improves detection of HLA antibodies in flow crossmatches.
Transplant Proc Volume: 33 Page(s): 473 - 474
01/01/2001 Authors: Vaidya S; Cooper TY; Stewart D; Gugliuzza K; Daller J; Bray RA -
Identification of undiagnosed chronic lymphocytic leukemia (CLL) in a potential renal allograft recipient via the final flow cytometric crossmatch.
Page(s): 113 - 114
01/01/2001 Authors: Bray RA; Holcomb J; Chapman P; Duenzl M; Mann KP; Whelchel J -
Reserve pluripotent stem cells resembling embryonic stem cells are present in adult humans
MOLECULAR BIOLOGY OF THE CELL Volume: 11 Page(s): 408A - 408A
12/01/2000 Authors: Young HE; Lucas PA; Yoder MC; Hixson DC; Bray RA; Hudson JA; Black AC -
Interobserver variability in the assessment of flow cytometric immunophenotyping of hematolymphoid neoplasms.
BLOOD Volume: 96 Page(s): 717A - 717A
11/16/2000 Authors: Holden JT; Bray RA; Braylan R; Chen SS; Duenzl ML; Frey T; Kamihira S; Ludwig WD; Orfao A; Ratei R -
Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
Transplantation Volume: 70 Page(s): 1055 - 1059
10/15/2000 Authors: Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD -
Longitudinal monitoring of WBC subsets in packed RBC units after filtration: implications for transfusion transmission of infections.
Transfusion Volume: 40 Page(s): 500 - 506
05/01/2000 Authors: Roback JD; Bray RA; Hillyer CD -
Prolongation of renal allograft survival by a chimeric anti-human CD40 monoclonal antibody in nonhuman primates.
TRANSPLANTATION Volume: 69 Page(s): S123 - S123
04/27/2000 Authors: Larsen CP; Odom K; Hollenbaugh D; Bray R; Hennigar R; Pearsen TC -
Moleuclar typing for solid organ transplantation: Is low resolution analysis enough?
TRANSPLANTATION Volume: 69 Page(s): S183 - S183
04/27/2000 Authors: Bray RA; Jones H; Bolin V; Thomas M; Gebel HM -
Improved detection of graft-damaging alloantibodies in 3-color flow crossmatches using pronase-digested lymphocytes.
TRANSPLANTATION Volume: 69 Page(s): S184 - S184
04/27/2000 Authors: Vaidya S; Cooper TY; Stewart D; Bray RA; Daller J; Fish JC; Gugliuzza KK -
Sensitization and sensitivity: defining the unsensitized patient.
Transplantation Volume: 69 Page(s): 1370 - 1374
04/15/2000 Authors: Gebel HM; Bray RA -
Hematopoietic response to lineage-non-specific (rrIL-3) and lineage-specific (rhG-CSF, rhEpo, rhTpo) cytokine administration in SIV-infected rhesus macaques is related to stage of infection.
J Med Primatol Volume: 29 Page(s): 47 - 56
04/01/2000 Authors: Bucur SZ; Gillespie TW; Lee ME; Adams JW; Bray RA; Villinger F; Ansari AA; Hillyer CD -
Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells.
Leukemia Volume: 14 Page(s): 412 - 418
03/01/2000 Authors: Boyer MW; Waller EK; Bray RA; Unangst T; Johnson TS; Phillips C; Jurickova I; Winton EF; Yeager AM -
Lack of CD45 expression in adult precursor B-lineage acute lymphoblastic leukemia may predict improved outcome
AMERICAN JOURNAL OF CLINICAL PATHOLOGY Volume: 112 Page(s): 563 - 563
10/01/1999 Authors: Fiebelkorn KR; Holden JT; Bray RA -
Human pluripotent and progenitor cells display cell surface cluster differentiation markers CD10, CD13, CD56, and MHC class-I.
Proc Soc Exp Biol Med Volume: 221 Page(s): 63 - 71
05/01/1999 Authors: Young HE; Steele TA; Bray RA; Detmer K; Blake LW; Lucas PW; Black AC -
Transplantation of unrelated placental/umbilical cord blood cells for leukocyte adhesion deficiency
PEDIATRIC RESEARCH Volume: 45 Page(s): 153A - 153A
04/01/1999 Authors: Silverman KJ; West CM; Ogden AK; Boyer MW; Olson E; Bray RA; Adamkiewicz TV; Yeager AM -
Human mesodermal stem cells display cell surface cluster differentiation markers.
FASEB JOURNAL Volume: 13 Page(s): A643 - A643
03/12/1999 Authors: Steele TA; Bray RA; Lucas PA; Blake LW; Detmer K; Black AC; Young HE -
KOR-SA3544 antigen positivity is not a predictor of BCR/ABL rearrangement in ALL.
LABORATORY INVESTIGATION Volume: 79 Page(s): 148A - 148A
01/01/1999 Authors: Whitehead JC; Bray RA; Farhi DC -
Changes in markers of CMV-infectivity with filter leukoreduction (LR) of red cells.
BLOOD Volume: 92 Page(s): 51A - 51A
11/15/1998 Authors: Roback JD; Bray RA; Hillyer CD -
Hematopoietic reserve and mobilization potential, and viral load during early and late stage SIV.
BLOOD Volume: 92 Page(s): 381A - 381A
11/15/1998 Authors: Bucur SZ; Gillespie TW; Lee ME; Adams JW; Bray RA; Villinger F; Winton EF; Novembre F; Ansari AA; Hillyer DC -
Bone marrow response to exogenously administered cytokines in a cohort of rhesus macaques infected with monocytotropic strain, SIVmac239 17E.
BLOOD Volume: 92 Page(s): 380A - 381A
11/15/1998 Authors: Bucur SZ; Gillespie TW; Lee ME; Adams JW; Bray RA; Villinger F; Winton EF; Novembre F; Ansari A; Hillyer CD -
Quantitation of CMV-associated leukocyte (WBC) subsets in red blood cell (RBC) units with leukoreduction (LR) and storage.
TRANSFUSION Volume: 38 Page(s): 106S - 106S
10/01/1998 Authors: Roback JD; Bray RA; Hillyer CD -
Hematologic and virologic effects of lineage-specific and non-lineage-specific recombinant human and rhesus cytokines in a cohort of SIVmac239-infected macaques.
AIDS Res Hum Retroviruses Volume: 14 Page(s): 651 - 660
05/20/1998 Authors: Bucur SZ; Lackey DA; Adams JW; Lee ME; Villinger F; Mayne A; Bray RA; Winton EF; Novembre F; Strobert EA -
A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning.
Blood Volume: 90 Page(s): 5013 - 5021
12/15/1997 Authors: Miraglia S; Godfrey W; Yin AH; Atkins K; Warnke R; Holden JT; Bray RA; Waller EK; Buck DW -
VOCs and PCBs: Risk factors for B-cell lymphoproliferative disorders?
BLOOD Volume: 90 Page(s): 3957 - 3957
11/15/1997 Authors: Slade BA; Vogt RF; Marti GE; Bray RA; Holden JT; Lybarger JA -
The number of CD34+, CD38- cells in the graft predicts the kinetics of hematopoietic reconstitution following autologous or allogeneic bone marrow transplantation (BMT).
BLOOD Volume: 90 Page(s): 1753 - 1753
11/15/1997 Authors: Waller EK; Lynn M; Worford L; Winton EF; Redei I; Heffner T; Hillyer CD; Smith K; Bucur S; Lopez R -
U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation.
Volume: 30 Page(s): 236 - 244
10/15/1997 Authors: Borowitz MJ; Bray R; Gascoyne R; Melnick S; Parker JW; Picker L; Stetler-Stevenson M -
Platelet recovery following autologous bone marrow transplantation correlates with the content of CD34+, CD38-cells in the marrow graft.
EXPERIMENTAL HEMATOLOGY Volume: 25 Page(s): 598 - 598
08/01/1997 Authors: Waller EK; Worford LJ; Lynn M; Winton EF; Bray RA; Jones W; Rosenthal H; McCollum J; Holland HK; Yeager AM -
Presence of minimal residual disease (MRD) in acute myelogenous leukemia (AML) patients preallogeneic bone marrow transplantation (BMT) is associated with a lower relapse-free survival (RFS).
EXPERIMENTAL HEMATOLOGY Volume: 25 Page(s): 621 - 621
08/01/1997 Authors: Holland HK; Bray RA; OToole K; Holden JT; Connaghan DG; Heffner LT; Waller EK; Winton EF; Yeager AM -
Multicenter evaluation of the flow cytometry T-cell crossmatch: results from the American Society of Histocompatibility and Immunogenetics-College of American Pathologists proficiency testing program.
Transplantation Volume: 63 Page(s): 1440 - 1445
05/27/1997 Authors: Scornik JC; Bray RA; Pollack MS; Cook DJ; Marrari M; Duquesnoy R; Langley JW -
CD34 expression on acute myelocytic leukemia cells.
Leuk Res Volume: 21 Page(s): 387 - 389
05/01/1997 Authors: Geller RB; Bray RA -
Is the cytotoxicity test an appropriate assay for use in new renal patient evaluations?
Volume: 55 Page(s): 76 - 76
01/01/1997 Authors: Holcomb JE; Beebe C; Bray RA -
Comparison between antiglobulin-enhanced cytotoxicity, flow cytometry and GTI quick screen for the detection of HLA alloantibody.
Volume: 55 Page(s): 74 - 74
01/01/1997 Authors: Bray RA; Foulks C; Wilmoth L; Chapman P; Holcomb J -
Flow cytometric detection of HLA alloantibodies using class I coated microparticles.
HUMAN IMMUNOLOGY Volume: 55 Page(s): 36 - 36
01/01/1997 Authors: Bray RA; Cook DJ; Gebel HM -
Studies of the effects of recombinant human (RH) and rhesus (RH) cytokines on hematologic and virologic parameters in a cohort SIVmac239 infected macaques.
BLOOD Volume: 88 Page(s): 1376 - 1376
11/15/1996 Authors: Hillyer CD; Lackey DA; Bucur SZ; Adams JW; Lee ME; Buccolo LS; Trainor LD; Villinger F; Mayne A; Bray RA -
Natural killer (NK) cell function and cytokine production in patients with AIDS and Mycobacterium avium complex (MAC) disease.
Volume: 23 Page(s): 121 - 121
10/01/1996 Authors: Ellis S; Scent G; Blanchard K; Bray R; Horsburgh R -
CD117/CD34 expression in leukemic blasts.
Am J Clin Pathol Volume: 106 Page(s): 192 - 195
08/01/1996 Authors: Wells SJ; Bray RA; Stempora LL; Farhi DC -
Lymphoid-associated antigen expression by acute myeloid leukemia.
Am J Clin Pathol Volume: 106 Page(s): 185 - 191
08/01/1996 Authors: Launder TM; Bray RA; Stempora L; Chenggis ML; Farhi DC -
Mantle cell vs small lymphocytic lymphoma: Diagnosis by surface light chain density
LABORATORY INVESTIGATION Volume: 74 Page(s): 655 - 655
01/01/1996 Authors: Holden JT; Farhi DC; Hendrix L; Stempora L; Bray RA -
HLA-DQ typing: A comparison of biotest DQB-ELPHA with serology and SSP-PCR.
Volume: 49 Page(s): 173 - 173
01/01/1996 Authors: Jones H; Holcomb J; Bray R; Rodey G; Maurer D -
The flow cytometric PRA: Evaluation of antibody reactivity and specificity using cell pools based on CREGs.
Volume: 49 Page(s): 128 - 128
01/01/1996 Authors: Bray RA; Chapman PT; Sinclair DA; Tate CA; Wilmoth LA; Holcomb JE; Rodey GE -
False negative flow cytometric crossmatchs following the use of LymphoKwik(TM).
Volume: 49 Page(s): 186 - 186
01/01/1996 Authors: Bray RA; vanderMeer J; Sinclair DA; Holcomb JE -
DNA index and ploidy distinguish normal human parathyroids from parathyroid adenomas and primary hyperplastic parathyroids.
Surgery Volume: 118 Page(s): 1041 - 1049
12/01/1995 Authors: Chryssochoos JT; Weber CJ; Cohen C; Moore J; DeRose PB; Hagler M; Bray R; Stempora L; Mainiero M; McGarity WC -
Total CD34+ cell content and CFU-GEMM are not good predictors of time to neutrophil engraftment following matched unrelated donor (MUD) transplantation.
BLOOD Volume: 86 Page(s): 467 - 467
11/15/1995 Authors: Holland HK; Geller RB; Redei S; Bray R; Winton EF; Connaghan DG; OToole K; Person L; Devine SM; Wingard JR -
The hematopoietic effects of recombinant human (rh) FLT3 ligand administered to non-human primates.
BLOOD Volume: 86 Page(s): 1681 - 1681
11/15/1995 Authors: Winton EF; Bucur SZ; Bray RA; Toba K; Williams DE; McClure HM; Lyman SD -
Transfusion-associated chronic cutaneous graft-versus-host disease.
J Am Acad Dermatol Volume: 33 Page(s): 327 - 332
08/01/1995 Authors: Hull RJ; Bray RA; Hillyer C; Swerlick RA -
Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia.
Blood Volume: 86 Page(s): 60 - 65
07/01/1995 Authors: Holden JT; Geller RB; Farhi DC; Holland HK; Stempora LL; Phillips CN; Bray RA -
THE USE OF DUAL-COLOR FLOW-CYTOMETRY FOR THE DETECTION OF INTRACELLULAR CYTOKINES
FASEB JOURNAL Volume: 9 Page(s): A536 - A536
03/09/1995 Authors: SINCLAIR DA; BRAY RA -
IDENTIFICATION OF UNIQUE NATURAL-KILLER (NK) CELL SUBSETS IN NORMAL AND HIV-INFECTED INDIVIDUALS UTILIZING MULTIPARAMETER FLOW-CYTOMETRY
FASEB JOURNAL Volume: 9 Page(s): A208 - A208
03/09/1995 Authors: MARUSA M; STEMPORA L; PARKER MA; BRAY RA -
AML EXPRESSING LYMPHOID-ASSOCIATED ANTIGENS
LABORATORY INVESTIGATION Volume: 72 Page(s): A114 - A114
01/01/1995 Authors: LAUNDER TM; FARHI DC; BRAY RA; HOLLAND HK; GELLER RB -
Low incidence of red cell and HLA antibody formation by bone marrow transplant patients.
Transfusion Volume: 35 Page(s): 931 - 935
01/01/1995 Authors: Abou-Elella AA; Camarillo TA; Allen MB; Barclay S; Pierce JA; Holland HK; Wingard JR; Bray RA; Rodey GE; Hillyer CD -
CD117 CD34 EXPRESSION IN LEUKEMIC BLASTS
LABORATORY INVESTIGATION Volume: 72 Page(s): A123 - A123
01/01/1995 Authors: WELLS SJ; FARHI DC; BRAY RA; STEMPORA LL; HOLLAND HK; GELLER RB -
UTILITY OF THY-1 EXPRESSION IN CD34+ ACUTE-LEUKEMIA
BLOOD Volume: 84 Page(s): A310 - A310
11/15/1994 Authors: HOLDEN JT; GELLER RB; FARHI DC; HOLLAND HK; STEMPORA LL; BRAY RA -
INTENSIVE TIME-SEQUENTIAL INDUCTION THERAPY WITH VP-16, MITOXANTRONE AND ARA-C FOR PATIENTS (PTS) WITH NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA (AML) OR REFRACTORY RELAPSE ACUTE-LEUKEMIA - A POTENTIAL ROLE FOR GM-CSF TO ENHANCE RECRUITMENT
BLOOD Volume: 84 Page(s): A144 - A144
11/15/1994 Authors: GELLER RB; MORRIS L; WINTON EF; BRAY R; HEFFNER LT; HOLLAND KH; GILMORE C; DEVINE S; FARHI D; JAMISON K -
Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients.
Hum Immunol Volume: 39 Page(s): 272 - 280
04/01/1994 Authors: Rodey GE; Neylan JF; Whelchel JD; Revels KW; Bray RA -
DETECTION OF ALLOANTIBODIES IN CCTS TRANSPLANT RECIPIENTS BY FLOW-CYTOMETRY
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Volume: 35 Page(s): 1896 - 1896
03/15/1994 Authors: BACA O; BRAY RA; STULTING RD -
CHRONIC MYELOGENOUS LEUKEMIA IN BLAST CRISIS - MULTIPARAMETER AND IMMUNOPHENOTYPIC ANALYSIS
LABORATORY INVESTIGATION Volume: 70 Page(s): A118 - A118
01/01/1994 Authors: PANKOWSKY DA; FARHI DC; BRAY RA; STEMPORA LL -
Flow cytometry crossmatching for solid organ transplantation.
Methods Cell Biol Volume: 41 Page(s): 103 - 119
01/01/1994 Authors: Bray RA -
ANTIERYTHROCYTE (RBC-AB) AND HLA ANTIBODY-FORMATION IN BONE-MARROW TRANSPLANT (BMT) PATIENTS ON A LARGE HOSPITAL-SERVICE
TRANSFUSION Volume: 33 Page(s): S64 - S64
09/01/1993 Authors: ABOUELELLA AA; ALLEN MB; BARCLAY S; PIERCE JA; HOLLAND HK; WINGARD JR; SARAL R; BRAY RA; RODEY GE; HILLYER CD -
CD34+ progenitors and colony-forming units-granulocyte macrophage are recruited during large-volume leukapheresis and concentrated by counterflow centrifugal elutriation.
Transfusion Volume: 33 Page(s): 316 - 321
04/01/1993 Authors: Hillyer CD; Lackey DA; Hart KK; Stempora LL; Bray RA; Bender JG; Donnenberg AD -
Flow cytometry in the transplant laboratory.
Ann N Y Acad Sci Volume: 677 Page(s): 138 - 151
03/20/1993 Authors: Bray RA -
FLOW-CYTOMETRY IN THE TRANSPLANT LABORATORY
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES Volume: 677 Page(s): 138 - 151
03/20/1993 Authors: BRAY RA -
PAST-POSITIVE CURRENT NEGATIVE FLOW CYTOMETRIC CROSS-MATCH ASSOCIATED WITH EARLY RENAL-ALLOGRAFT LOSS
HUMAN IMMUNOLOGY Volume: 37 Page(s): 103 - 103
01/01/1993 Authors: SINCLAIR D; RODEY G; LOWANCE D; WHELCHEL J; BRAY R -
Improved staining method for the simultaneous flow cytofluorometric analysis of DNA content, S-phase fraction, and surface phenotype using single laser instrumentation.
Cytometry Volume: 13 Page(s): 60 - 67
01/01/1992 Authors: Toba K; Winton EF; Bray RA -
Identification of a population of large granular lymphocytes obtained from the rheumatoid joint coexpressing the CD3 and CD16 antigens.
Clin Immunol Immunopathol Volume: 58 Page(s): 409 - 418
03/01/1991 Authors: Bray RA; Pope RM; Landay AL -
AUTOCRINE GROWTH-STIMULATION OF UROTHELIAL CARCINOMA BY EPIDERMAL GROWTH-FACTOR (EGF)
Volume: 64 Page(s): A46 - A46
01/01/1991 Authors: GANSLER T; WATTS L; STEMPORA L; VELIMIROVICH B; BRAY R; GRAHAM S -
Two populations of CD56 (Leu-19)+/CD16+ cells in bone marrow transplant recipients.
Bone Marrow Transplant Volume: 5 Page(s): 259 - 264
04/01/1990 Authors: Gottschalk LR; Bray RA; Kaizer H; Gebel HM -
The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities.
Transplantation Volume: 48 Page(s): 834 - 840
11/01/1989 Authors: Bray RA; Lebeck LK; Gebel HM -
The detection and interpretation of urinary eosinophils.
Arch Pathol Lab Med Volume: 113 Page(s): 1256 - 1258
11/01/1989 Authors: Corwin HL; Bray RA; Haber MH -
T cells from patients successfully treated with OKT3 do not react with the T-cell receptor antibody.
Hum Immunol Volume: 26 Page(s): 123 - 129
10/01/1989 Authors: Gebel HM; Lebeck LK; Jensik SC; Webster K; Bray RA -
Identification and functional characterization of mononuclear cells by flow cytometry.
Arch Pathol Lab Med Volume: 113 Page(s): 579 - 590
06/01/1989 Authors: Bray RA; Landay AL -
DISCORDANT EXPRESSION OF CD3 AND T-CELL RECEPTOR ANTIGENS ON LYMPHOCYTES FROM PATIENTS TREATED WITH OKT3
TRANSPLANTATION PROCEEDINGS Volume: 21 Page(s): 1745 - 1746
02/01/1989 Authors: GEBEL HM; LEBECK LL; JENSIK SC; LANDAY AL; BRAY RA -
Discordant expression of CD3 and T-cell receptor antigens on lymphocytes from patients treated with OKT3.
Transplant Proc Volume: 21 Page(s): 1745 - 1746
02/01/1989 Authors: Gebel HM; Lebeck LL; Jensik SC; Landay AL; Bray RA -
DISCRIMINATION OF CLASS-I ANTIBODIES IN THE FLOW CYTOMETRIC CROSSMATCH (FCXM)
HUMAN IMMUNOLOGY Volume: 23 Page(s): 83 - 83
10/01/1988 Authors: BRAY RA; GEBEL HM -
LACK OF T-CELL RECEPTOR MOLECULES ON LYMPHOCYTES-CD3 FROM PATIENTS TREATED WITH OKT3
HUMAN IMMUNOLOGY Volume: 23 Page(s): 99 - 100
10/01/1988 Authors: GEBEL HM; LEBECK LL; JENSIK SC; BRAY RA -
Preferential expression of neo-CRP epitopes on the surface of human peripheral blood lymphocytes.
Cell Immunol Volume: 116 Page(s): 86 - 98
10/01/1988 Authors: Samberg NL; Bray RA; Gewurz H; Landay AL; Potempa LA -
Flow cytometry of urine.
Clin Lab Med Volume: 8 Page(s): 541 - 553
09/01/1988 Authors: Landay AL; Bray RA -
C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP.
J Immunol Volume: 140 Page(s): 4271 - 4278
06/15/1988 Authors: Bray RA; Samberg NL; Gewurz H; Potempa LA; Landay AL -
NATURAL-KILLER CELL SUBPOPULATIONS IN BONE-MARROW TRANSPLANT RECIPIENTS
FASEB JOURNAL Volume: 2 Page(s): A1851 - A1851
03/25/1988 Authors: LANDAY AL; GOTTSCHALK LR; BRAY RA; GEBEL HM -
4-Hydroxynonenal: a specific indicator for canine neuronal-retinal ceroidosis.
Am J Med Genet Suppl Volume: 5 Page(s): 171 - 181
01/01/1988 Authors: Siakotos AN; Bray R; Dratz E; van Kuijk F; Sevanian A; Koppang N -
T-cell receptor gene rearrangement and expression in human natural killer cells: natural killer activity is not dependent on the rearrangement and expression of T-cell receptor alpha, beta, or gamma genes.
Immunogenetics Volume: 27 Page(s): 231 - 238
01/01/1988 Authors: Leiden JM; Gottesdiener KM; Quertermous T; Coury L; Bray RA; Gottschalk L; Gebel H; Seidman JG; Strominger JL; Landay AL -
DUAL ROLE FOR IL-2 IN ACTIVATION AND MATURATION OF HUMAN NK CELLS
JOURNAL OF LEUKOCYTE BIOLOGY Volume: 42 Page(s): 380 - 380
10/01/1987 Authors: GEBEL H; LANDAY A; BRAY R -
EFFECTS OF MARINE LIPIDS ON HUMAN MONOCYTE AND NATURAL-KILLER-CELL ACTIVITIES IN TYPE-1 DIABETIC WOMEN
Volume: 35 Page(s): A896 - A896
10/01/1987 Authors: ZELLER JM; BRAY RA; LEVY RA; BAGDADE JD -
PREFERENTIAL EXPRESSION OF CRP NEOANTIGEN ON CELLS OF PATIENTS WITH CLONAL EXPANSIONS OF B-CELLS AND LGLS
CLINICAL RESEARCH Volume: 35 Page(s): A889 - A889
10/01/1987 Authors: BRAY RA; SAMBERG NL; POTEMPA LA; GEWURZ H; LANDAY AL -
HUMAN PERIPHERAL-BLOOD NATURAL-KILLER (NK) CELLS AND LYMPHOCYTES-B SHARE A COMMON DETERMINANT RECOGNIZED BY ANTIBODIES AGAINST A NOVEL FORM OF C-REACTIVE PROTEIN (CRP)
JOURNAL OF LEUKOCYTE BIOLOGY Volume: 42 Page(s): 379 - 379
10/01/1987 Authors: BRAY RA; SAMBERG NL; GEWURZ H; POTEMPA LA; LANDAY AL -
ANTIBODIES TO THE NEO-ANTIGENIC BUT NOT THE NATIVE-ANTIGENIC FORM OF HUMAN C-REACTIVE PROTEIN ARE REACTIVE WITH NORMAL PERIPHERAL-BLOOD LYMPHOCYTES
JOURNAL OF LEUKOCYTE BIOLOGY Volume: 42 Page(s): 350 - 350
10/01/1987 Authors: SAMBERG NL; BRAY RA; GEWURZ H; LANDAY AL; POTEMPA LA -
Differential surface marker expression in patients with CD-16+ lymphoproliferative disorders: in vivo model for NK differentiation.
Hum Immunol Volume: 19 Page(s): 105 - 115
06/01/1987 Authors: Bray RA; Gottschalk LR; Landay AL; Gebel HM -
AN INVIVO MODEL TO STUDY NK-CELL DIFFERENTIATION
FEDERATION PROCEEDINGS Volume: 46 Page(s): 608 - 608
03/01/1987 Authors: BRAY RA; GOTTSCHALK LR; LANDAY AL; GEBEL HM -
Determination of helper:suppressor T-cell ratios.
N Engl J Med Volume: 316 Page(s): 113
01/08/1987 Authors: Gebel HM; Anderson JE; Gottschalk LR; Bray RA -
LIPOXYGENATION IS REQUIRED IN NK CELL ACTIVATION POSSIBLY AS A MEANS TO GENERATE OXYGEN RADICALS
IMMUNOBIOLOGY Volume: 173 Page(s): 356 - 357
11/01/1986 Authors: BRAHMI Z; BRAY R -
DIFFERENTIAL EXPRESSION OF HLA-DR AND DQ ON NK-CELLS - POSSIBLE RELATIONSHIP TO NK-ONTOGENY
HUMAN IMMUNOLOGY Volume: 17 Page(s): 208 - 208
10/01/1986 Authors: GOTTSCHALK L; BRAY RA; LANDAY A; KAIZER H; GEBEL H -
Role of lipoxygenation in human natural killer cell activation.
J Immunol Volume: 136 Page(s): 1783 - 1790
03/01/1986 Authors: Bray RA; Brahmi Z -
THE EXPRESSION OF A NEO-ANTIGENIC SPECIFICITY OF C-REACTIVE PROTEIN (CRP) ON THE SURFACE OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS (PBMC)
FEDERATION PROCEEDINGS Volume: 45 Page(s): 262 - 262
03/01/1986 Authors: SAMBERG NL; BRAY RA; LANDAY AL; SEIGEL J; GEWURZ H; POTEMPA LA -
EVIDENCE THAT LIPOXYGENATION MAY PROVIDE OXYGEN RADICALS NECESSARY FOR NK CELL ACTIVATION
FEDERATION PROCEEDINGS Volume: 45 Page(s): 629 - 629
03/01/1986 Authors: BRAY RA; BRAHMI Z -
Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanism.
J Immunol Volume: 135 Page(s): 4108 - 4113
12/01/1985 Authors: Brahmi Z; Bray RA; Abrams SI -
Mechanism of action of phorbol myristate acetate on human natural killer cell activity.
Cell Immunol Volume: 80 Page(s): 230 - 240
09/01/1983 Authors: Abrams SI; Bray RA; Brahmi Z -
Studies on the mechanism of human natural killer cell-mediated cytolysis. I. Modulation by dexamethasone and arachidonic acid.
Cell Immunol Volume: 78 Page(s): 100 - 113
05/01/1983 Authors: Bray R; Abrams S; Brahmi Z -
MODULATION OF NATURAL-KILLER CELL-MEDIATED CYTOLYSIS BY DEXAMETHASONE AND ARACHIDONIC-ACID
FEDERATION PROCEEDINGS Volume: 42 Page(s): 1198 - 1198
01/01/1983 Authors: BRAY RA; BRAHMI Z -
NATURAL ATTACHMENT AND KILLING OF MALIGNANT TARGETS BY FRACTIONATED BLOOD LEUKOCYTES
FEDERATION PROCEEDINGS Volume: 41 Page(s): 601 - 601
01/01/1982 Authors: BRAHMI Z; LAZARUS K; HUBBARD A; BRAY R; BUTTERICK C; BAEHNER R